AGE|AGE_SPECIFIC_CI_LOWER|AGE_SPECIFIC_CI_UPPER|AGE_SPECIFIC_RATE|COUNT|EVENT_TYPE|POPULATION|SITE|YEAR
10-14|2.3|2.7|2.5|503|Mortality|20213364|All Cancer Sites Combined|1999
5-9|10.6|11.6|11.1|2079|Incidence|18696975|All Cancer Sites Combined|1999
1-4|0.6|0.9|0.7|113|Mortality|15339782|Brain and Other Nervous System|1999
1-4|2.5|3.0|2.7|418|Mortality|15339782|All Cancer Sites Combined|1999
15-19|3.4|4.0|3.7|745|Mortality|20084602|All Cancer Sites Combined|1999
10-14|11.9|12.9|12.4|2267|Incidence|18331872|All Cancer Sites Combined|1999
<1|~|~|~|~|Mortality|3795762|Brain and Other Nervous System|1999
<1|2.8|4.1|3.4|117|Incidence|3432436|Brain and Other Nervous System|1999
1-4|3.5|4.2|3.8|533|Incidence|13908887|Brain and Other Nervous System|1999
5-9|3.1|3.6|3.3|623|Incidence|18696975|Brain and Other Nervous System|1999
15-19|~|~|~|~|Mortality|20084602|Kidney and Renal Pelvis|1999
<1|~|~|~|~|Mortality|3795762|Kidney and Renal Pelvis|1999
1-4|~|~|~|~|Mortality|15339782|Hodgkin Lymphoma|1999
<1|1.5|2.5|2.0|67|Incidence|3432436|Kidney and Renal Pelvis|1999
10-14|1.0|1.3|1.1|207|Incidence|18331872|Hodgkin Lymphoma|1999
15-19|2.8|3.3|3.1|558|Incidence|18177976|Hodgkin Lymphoma|1999
15-19|0.1|0.2|0.2|31|Mortality|20084602|Hodgkin Lymphoma|1999
<1|~|~|~|~|Mortality|3795762|Hodgkin Lymphoma|1999
1-4|~|~|~|~|Incidence|13908887|Hodgkin Lymphoma|1999
5-9|0.8|1.0|0.9|184|Mortality|20606460|Brain and Other Nervous System|1999
1-4|1.6|2.1|1.9|260|Incidence|13908887|Kidney and Renal Pelvis|1999
15-19|0.1|0.2|0.1|27|Incidence|18177976|Kidney and Renal Pelvis|1999
10-14|~|~|~|~|Mortality|20213364|Kidney and Renal Pelvis|1999
5-9|~|~|~|~|Mortality|20606460|Hodgkin Lymphoma|1999
<1|~|~|~|~|Incidence|3432436|Hodgkin Lymphoma|1999
10-14|0.1|0.2|0.1|25|Mortality|20213364|Non-Hodgkin Lymphoma|1999
1-4|0.1|0.2|0.1|16|Mortality|15339782|Non-Hodgkin Lymphoma|1999
1-4|0.6|0.9|0.7|98|Incidence|13908887|Non-Hodgkin Lymphoma|1999
15-19|1.4|1.8|1.6|286|Incidence|18177976|Non-Hodgkin Lymphoma|1999
<1|~|~|~|~|Incidence|3432436|Non-Hodgkin Lymphoma|1999
10-14|11.8|12.8|12.3|2295|Incidence|18696519|All Cancer Sites Combined|2000
15-19|0.4|0.6|0.5|105|Mortality|20259270|Brain and Other Nervous System|2000
1-4|19.7|21.2|20.5|2844|Incidence|13887421|All Cancer Sites Combined|2000
<1|1.9|2.9|2.4|92|Mortality|3855509|All Cancer Sites Combined|2000
5-9|0.7|0.9|0.8|166|Mortality|20474990|Brain and Other Nervous System|2000
<1|3.2|4.6|3.9|135|Incidence|3485395|Brain and Other Nervous System|2000
10-14|1.1|1.5|1.3|240|Incidence|18696519|Hodgkin Lymphoma|2000
5-9|0.3|0.5|0.4|67|Incidence|18571375|Hodgkin Lymphoma|2000
5-9|0.5|0.7|0.6|113|Incidence|18571375|Kidney and Renal Pelvis|2000
<1|21.9|25.1|23.5|818|Incidence|3485395|All Cancer Sites Combined|2000
1-4|2.5|3.0|2.7|420|Mortality|15330856|All Cancer Sites Combined|2000
5-9|11.1|12.0|11.5|2143|Incidence|18571375|All Cancer Sites Combined|2000
1-4|~|~|~|~|Mortality|15330856|Kidney and Renal Pelvis|2000
<1|~|~|~|~|Mortality|3855509|Kidney and Renal Pelvis|2000
<1|~|~|~|~|Mortality|3855509|Hodgkin Lymphoma|2000
<1|1.4|2.3|1.8|68|Mortality|3795762|All Cancer Sites Combined|1999
10-14|0.5|0.7|0.6|124|Mortality|20213364|Brain and Other Nervous System|1999
10-14|~|~|~|~|Mortality|20213364|Hodgkin Lymphoma|1999
1-4|0.1|0.2|0.1|19|Mortality|15339782|Kidney and Renal Pelvis|1999
5-9|0.4|0.7|0.5|100|Incidence|18696975|Kidney and Renal Pelvis|1999
15-19|19.1|20.4|19.8|3591|Incidence|18177976|All Cancer Sites Combined|1999
15-19|3.3|3.9|3.6|732|Mortality|20297606|All Cancer Sites Combined|2001
5-9|0.1|0.2|0.1|23|Mortality|20606460|Kidney and Renal Pelvis|1999
10-14|0.1|0.2|0.1|24|Mortality|20618738|Non-Hodgkin Lymphoma|2000
5-9|~|~|~|~|Mortality|20606460|Non-Hodgkin Lymphoma|1999
<1|~|~|~|~|Mortality|3795762|Non-Hodgkin Lymphoma|1999
<1|~|~|~|~|Incidence|3485395|Non-Hodgkin Lymphoma|2000
15-19|3.4|4.0|3.7|745|Mortality|20259270|All Cancer Sites Combined|2000
<1|0.3|0.8|0.5|20|Mortality|3855509|Brain and Other Nervous System|2000
5-9|2.3|2.7|2.5|509|Mortality|20606460|All Cancer Sites Combined|1999
<1|22.3|25.6|23.9|822|Incidence|3432436|All Cancer Sites Combined|1999
15-19|0.5|0.7|0.6|115|Mortality|20084602|Brain and Other Nervous System|1999
15-19|20.6|21.9|21.2|4069|Incidence|19191395|All Cancer Sites Combined|2001
15-19|0.1|0.2|0.2|30|Incidence|19191395|Kidney and Renal Pelvis|2001
5-9|0.3|0.5|0.4|76|Incidence|18696975|Hodgkin Lymphoma|1999
15-19|1.6|2.0|1.8|323|Incidence|18341898|Non-Hodgkin Lymphoma|2000
10-14|1.0|1.3|1.1|214|Incidence|18696519|Non-Hodgkin Lymphoma|2000
1-4|18.9|20.4|19.6|2731|Incidence|13908887|All Cancer Sites Combined|1999
10-14|1.0|1.3|1.2|234|Incidence|19760108|Hodgkin Lymphoma|2001
5-9|2.2|2.6|2.4|489|Mortality|20474990|All Cancer Sites Combined|2000
10-14|2.4|2.8|2.6|474|Incidence|18331872|Brain and Other Nervous System|1999
10-14|~|~|~|~|Mortality|20618738|Kidney and Renal Pelvis|2000
10-14|0.1|0.2|0.1|24|Incidence|18331872|Kidney and Renal Pelvis|1999
10-14|2.5|3.0|2.8|515|Incidence|18696519|Brain and Other Nervous System|2000
10-14|0.6|0.9|0.7|150|Mortality|20618738|Brain and Other Nervous System|2000
<1|~|~|~|~|Mortality|4026137|Non-Hodgkin Lymphoma|2001
5-9|~|~|~|~|Mortality|20229583|Non-Hodgkin Lymphoma|2001
15-19|1.6|1.9|1.8|336|Incidence|19191395|Non-Hodgkin Lymphoma|2001
15-19|1.8|2.2|2.0|364|Incidence|18177976|Brain and Other Nervous System|1999
1-4|~|~|~|~|Mortality|15330856|Hodgkin Lymphoma|2000
<1|~|~|~|~|Incidence|3485395|Hodgkin Lymphoma|2000
5-9|0.7|1.0|0.8|157|Incidence|18696975|Non-Hodgkin Lymphoma|1999
5-9|0.1|0.2|0.1|21|Mortality|20474990|Kidney and Renal Pelvis|2000
10-14|0.1|0.2|0.1|22|Incidence|18696519|Kidney and Renal Pelvis|2000
10-14|2.3|2.8|2.5|535|Mortality|21098045|All Cancer Sites Combined|2002
5-9|3.1|3.6|3.3|637|Incidence|19141933|Brain and Other Nervous System|2001
<1|3.1|4.4|3.7|142|Incidence|3806227|Brain and Other Nervous System|2001
1-4|0.5|0.8|0.6|85|Incidence|13887421|Non-Hodgkin Lymphoma|2000
1-4|~|~|~|~|Mortality|15322194|Hodgkin Lymphoma|2001
<1|~|~|~|~|Mortality|4026137|Hodgkin Lymphoma|2001
10-14|12.2|13.2|12.7|2522|Incidence|19925443|All Cancer Sites Combined|2002
<1|22.9|26.1|24.5|921|Incidence|3761784|All Cancer Sites Combined|2002
1-4|0.1|0.2|0.1|22|Mortality|15322194|Kidney and Renal Pelvis|2001
5-9|0.1|0.2|0.1|30|Mortality|20229583|Kidney and Renal Pelvis|2001
15-19|0.1|0.2|0.1|27|Mortality|20346043|Hodgkin Lymphoma|2002
15-19|3.0|3.5|3.2|624|Incidence|19203368|Hodgkin Lymphoma|2002
15-19|0.2|0.4|0.3|60|Mortality|20259270|Non-Hodgkin Lymphoma|2000
5-9|0.1|0.2|0.1|23|Mortality|20474990|Non-Hodgkin Lymphoma|2000
1-4|3.7|4.4|4.0|556|Incidence|13887421|Brain and Other Nervous System|2000
5-9|3.1|3.7|3.4|630|Incidence|18571375|Brain and Other Nervous System|2000
1-4|~|~|~|~|Incidence|14671443|Hodgkin Lymphoma|2002
5-9|~|~|~|~|Mortality|20474990|Hodgkin Lymphoma|2000
1-4|0.1|0.2|0.1|16|Incidence|13887421|Hodgkin Lymphoma|2000
<1|~|~|~|~|Incidence|3806227|Non-Hodgkin Lymphoma|2001
1-4|1.9|2.4|2.1|296|Incidence|13887421|Kidney and Renal Pelvis|2000
5-9|~|~|~|~|Mortality|19965243|Non-Hodgkin Lymphoma|2002
1-4|2.5|3.0|2.7|420|Mortality|15322194|All Cancer Sites Combined|2001
15-19|2.9|3.4|3.1|573|Incidence|18341898|Hodgkin Lymphoma|2000
1-4|0.5|0.8|0.7|100|Mortality|15322194|Brain and Other Nervous System|2001
15-19|~|~|~|~|Mortality|20259270|Kidney and Renal Pelvis|2000
<1|1.1|2.0|1.5|53|Incidence|3485395|Kidney and Renal Pelvis|2000
<1|~|~|~|~|Mortality|4026137|Kidney and Renal Pelvis|2001
5-9|0.4|0.6|0.5|96|Incidence|19141933|Kidney and Renal Pelvis|2001
1-4|20.9|22.4|21.6|3135|Incidence|14487799|All Cancer Sites Combined|2001
5-9|11.0|11.9|11.4|2187|Incidence|19141933|All Cancer Sites Combined|2001
<1|~|~|~|~|Mortality|3985649|Hodgkin Lymphoma|2002
1-4|0.6|0.8|0.7|104|Mortality|15330856|Brain and Other Nervous System|2000
1-4|2.3|2.9|2.6|402|Mortality|15548021|All Cancer Sites Combined|2002
<1|1.5|2.4|1.9|72|Incidence|3806227|Kidney and Renal Pelvis|2001
5-9|0.1|0.2|0.1|23|Mortality|19965243|Kidney and Renal Pelvis|2002
15-19|0.4|0.6|0.5|108|Mortality|20346043|Brain and Other Nervous System|2002
<1|~|~|~|~|Mortality|3855509|Non-Hodgkin Lymphoma|2000
15-19|20.8|22.1|21.4|4297|Incidence|20061631|All Cancer Sites Combined|2003
15-19|~|~|~|~|Mortality|20297606|Kidney and Renal Pelvis|2001
15-19|3.1|3.6|3.4|690|Mortality|20446240|All Cancer Sites Combined|2003
1-4|~|~|~|~|Mortality|15330856|Non-Hodgkin Lymphoma|2000
10-14|1.1|1.4|1.3|252|Incidence|19760108|Non-Hodgkin Lymphoma|2001
<1|~|~|~|~|Mortality|3985649|Kidney and Renal Pelvis|2002
10-14|0.1|0.2|0.1|25|Incidence|19925443|Kidney and Renal Pelvis|2002
1-4|3.8|4.5|4.2|641|Incidence|15428404|Brain and Other Nervous System|2003
5-9|~|~|~|~|Mortality|19965243|Hodgkin Lymphoma|2002
10-14|~|~|~|~|Mortality|21178064|Hodgkin Lymphoma|2003
5-9|~|~|~|~|Mortality|19737870|Hodgkin Lymphoma|2003
<1|1.4|2.3|1.8|72|Incidence|3954649|Kidney and Renal Pelvis|2003
10-14|2.4|2.9|2.6|524|Incidence|19925443|Brain and Other Nervous System|2002
1-4|1.8|2.2|2.0|293|Incidence|14671443|Kidney and Renal Pelvis|2002
5-9|2.5|2.9|2.7|537|Mortality|19965243|All Cancer Sites Combined|2002
1-4|~|~|~|~|Mortality|15548021|Hodgkin Lymphoma|2002
10-14|0.1|0.2|0.1|28|Mortality|21178064|Non-Hodgkin Lymphoma|2003
15-19|1.9|2.3|2.1|406|Incidence|19191395|Brain and Other Nervous System|2001
<1|3.3|4.6|3.9|148|Incidence|3761784|Brain and Other Nervous System|2002
<1|~|~|~|~|Incidence|3954649|Non-Hodgkin Lymphoma|2003
10-14|2.3|2.7|2.5|515|Mortality|20887927|All Cancer Sites Combined|2001
15-19|1.6|2.0|1.8|341|Incidence|19203368|Non-Hodgkin Lymphoma|2002
15-19|0.1|0.2|0.1|23|Incidence|18341898|Kidney and Renal Pelvis|2000
5-9|0.7|1.0|0.8|170|Mortality|20229583|Brain and Other Nervous System|2001
10-14|2.5|2.9|2.7|534|Incidence|19760108|Brain and Other Nervous System|2001
<1|1.3|2.1|1.6|66|Mortality|4026137|All Cancer Sites Combined|2001
15-19|0.2|0.3|0.2|44|Mortality|20346043|Non-Hodgkin Lymphoma|2002
1-4|0.6|0.9|0.7|114|Mortality|15548021|Brain and Other Nervous System|2002
<1|~|~|~|~|Mortality|3985649|Brain and Other Nervous System|2002
5-9|~|~|~|~|Mortality|20229583|Hodgkin Lymphoma|2001
5-9|0.4|0.5|0.4|84|Incidence|19141933|Hodgkin Lymphoma|2001
5-9|2.4|2.6|2.5|2466|Mortality|98315139|All Cancer Sites Combined|2003-2007
10-14|~|~|~|~|Mortality|20887927|Hodgkin Lymphoma|2001
1-4|2.3|2.7|2.5|392|Mortality|15738126|All Cancer Sites Combined|2003
15-19|0.1|0.2|0.1|25|Mortality|20297606|Hodgkin Lymphoma|2001
15-19|3.0|3.5|3.2|622|Incidence|19191395|Hodgkin Lymphoma|2001
<1|~|~|~|~|Incidence|3806227|Hodgkin Lymphoma|2001
<1|1.5|2.4|1.9|72|Incidence|3761784|Kidney and Renal Pelvis|2002
1-4|0.1|0.1|0.1|71|Incidence|78339910|Hodgkin Lymphoma|2003-2007
10-14|0.1|0.3|0.2|42|Mortality|21098045|Non-Hodgkin Lymphoma|2002
10-14|1.0|1.3|1.1|225|Incidence|19925443|Non-Hodgkin Lymphoma|2002
<1|1.5|2.3|1.9|75|Mortality|4032152|All Cancer Sites Combined|2003
1-4|~|~|~|~|Mortality|15322194|Non-Hodgkin Lymphoma|2001
5-9|2.9|3.5|3.2|618|Incidence|19353639|Brain and Other Nervous System|2003
15-19|3.0|3.5|3.2|646|Incidence|20061631|Hodgkin Lymphoma|2003
<1|~|~|~|~|Incidence|20070646|Hodgkin Lymphoma|2003-2007
15-19|0.1|0.2|0.1|29|Incidence|20061631|Kidney and Renal Pelvis|2003
10-14|0.5|0.8|0.6|135|Mortality|21098045|Brain and Other Nervous System|2002
1-4|0.1|0.2|0.1|18|Incidence|15428404|Hodgkin Lymphoma|2003
5-9|0.9|1.2|1.0|202|Mortality|19965243|Brain and Other Nervous System|2002
5-9|10.8|11.7|11.2|2173|Incidence|19353639|All Cancer Sites Combined|2003
1-4|4.0|4.7|4.3|634|Incidence|14671443|Brain and Other Nervous System|2002
15-19|1.9|2.4|2.2|413|Incidence|19203368|Brain and Other Nervous System|2002
<1|0.3|0.7|0.4|18|Mortality|4032152|Brain and Other Nervous System|2003
10-14|~|~|~|~|Mortality|21178064|Kidney and Renal Pelvis|2003
1-4|20.4|21.9|21.1|3100|Incidence|14671443|All Cancer Sites Combined|2002
5-9|0.3|0.5|0.4|84|Incidence|19353639|Hodgkin Lymphoma|2003
5-9|0.1|0.2|0.1|28|Mortality|19737870|Kidney and Renal Pelvis|2003
5-9|0.9|1.1|1.0|191|Incidence|19353639|Non-Hodgkin Lymphoma|2003
15-19|0.0|0.1|0.1|16|Mortality|20446240|Hodgkin Lymphoma|2003
10-14|~|~|~|~|Mortality|21098045|Hodgkin Lymphoma|2002
1-4|~|~|~|~|Mortality|15548021|Kidney and Renal Pelvis|2002
15-19|0.1|0.2|0.1|25|Incidence|19203368|Kidney and Renal Pelvis|2002
10-14|1.1|1.4|1.2|239|Incidence|19925443|Hodgkin Lymphoma|2002
5-9|0.4|0.6|0.5|93|Incidence|18856401|Kidney and Renal Pelvis|2002
1-4|~|~|~|~|Mortality|15738126|Hodgkin Lymphoma|2003
5-9|~|~|~|~|Mortality|19579623|Hodgkin Lymphoma|2004
15-19|~|~|~|~|Mortality|20446240|Kidney and Renal Pelvis|2003
1-4|0.6|0.9|0.7|112|Incidence|15428404|Non-Hodgkin Lymphoma|2003
<1|0.9|1.6|1.2|50|Incidence|4092369|Kidney and Renal Pelvis|2004
1-4|2.3|2.5|2.4|1909|Mortality|80636900|All Cancer Sites Combined|2003-2007
<1|1.6|2.0|1.8|372|Mortality|20659486|All Cancer Sites Combined|2003-2007
15-19|1.5|1.8|1.6|330|Incidence|20061631|Non-Hodgkin Lymphoma|2003
<1|0.3|0.5|0.4|86|Mortality|20659486|Brain and Other Nervous System|2003-2007
15-19|2.2|2.3|2.3|2298|Incidence|102079321|Brain and Other Nervous System|2003-2007
<1|~|~|~|~|Incidence|3761784|Non-Hodgkin Lymphoma|2002
10-14|0.6|0.7|0.7|695|Mortality|103954108|Brain and Other Nervous System|2003-2007
1-4|21.1|22.5|21.8|3481|Incidence|15966362|All Cancer Sites Combined|2004
1-4|20.6|21.3|20.9|16404|Incidence|78339910|All Cancer Sites Combined|2003-2007
<1|0.0|0.1|0.1|17|Mortality|20659486|Kidney and Renal Pelvis|2003-2007
<1|3.1|4.3|3.7|145|Incidence|3954649|Brain and Other Nervous System|2003
10-14|2.3|2.5|2.4|2495|Mortality|103954108|All Cancer Sites Combined|2003-2007
15-19|3.1|3.4|3.2|3308|Incidence|102079321|Hodgkin Lymphoma|2003-2007
5-9|0.5|0.6|0.5|513|Incidence|95517738|Kidney and Renal Pelvis|2003-2007
15-19|0.0|0.1|0.1|17|Mortality|20677486|Hodgkin Lymphoma|2004
5-9|0.4|0.4|0.4|380|Incidence|95517738|Hodgkin Lymphoma|2003-2007
10-14|0.0|0.0|0.0|22|Mortality|103954108|Hodgkin Lymphoma|2003-2007
10-14|0.1|0.1|0.1|121|Mortality|103954108|Non-Hodgkin Lymphoma|2003-2007
<1|1.4|1.8|1.6|315|Incidence|20070646|Kidney and Renal Pelvis|2003-2007
15-19|0.1|0.1|0.1|78|Mortality|104809251|Hodgkin Lymphoma|2003-2007
15-19|~|~|~|~|Mortality|20677486|Kidney and Renal Pelvis|2004
5-9|0.1|0.2|0.1|23|Mortality|19579623|Kidney and Renal Pelvis|2004
1-4|~|~|~|~|Mortality|15738126|Non-Hodgkin Lymphoma|2003
5-9|0.1|0.1|0.1|17|Mortality|19737870|Non-Hodgkin Lymphoma|2003
<1|~|~|~|~|Incidence|3954649|Hodgkin Lymphoma|2003
5-9|0.9|1.0|0.9|905|Incidence|95517738|Non-Hodgkin Lymphoma|2003-2007
10-14|~|~|~|~|Mortality|20823279|Hodgkin Lymphoma|2005
15-19|~|~|~|~|Mortality|20993786|Hodgkin Lymphoma|2005
<1|~|~|~|~|Mortality|4101644|Hodgkin Lymphoma|2005
1-4|0.1|0.2|0.1|16|Incidence|16199802|Hodgkin Lymphoma|2005
5-9|0.4|0.6|0.5|102|Incidence|19353639|Kidney and Renal Pelvis|2003
15-19|0.2|0.3|0.2|49|Incidence|20993786|Kidney and Renal Pelvis|2005
5-9|2.5|2.9|2.7|526|Mortality|19579623|All Cancer Sites Combined|2004
5-9|~|~|~|~|Mortality|98315139|Hodgkin Lymphoma|2003-2007
<1|~|~|~|~|Mortality|20659486|Non-Hodgkin Lymphoma|2003-2007
15-19|1.5|1.8|1.7|344|Incidence|20677486|Non-Hodgkin Lymphoma|2004
5-9|0.8|1.1|0.9|186|Mortality|19579623|Brain and Other Nervous System|2004
1-4|~|~|~|~|Mortality|80636900|Hodgkin Lymphoma|2003-2007
10-14|12.9|13.9|13.4|2834|Incidence|21098577|All Cancer Sites Combined|2004
1-4|~|~|~|~|Mortality|15966362|Hodgkin Lymphoma|2004
<1|0.3|0.7|0.5|19|Mortality|4092369|Brain and Other Nervous System|2004
1-4|1.9|2.1|2.0|1552|Incidence|78339910|Kidney and Renal Pelvis|2003-2007
1-4|4.1|4.7|4.4|701|Incidence|15966362|Brain and Other Nervous System|2004
10-14|2.1|2.6|2.3|493|Mortality|21098577|All Cancer Sites Combined|2004
10-14|2.3|2.8|2.6|531|Incidence|20823279|Brain and Other Nervous System|2005
5-9|0.4|0.6|0.5|94|Incidence|19579623|Kidney and Renal Pelvis|2004
10-14|1.2|1.3|1.2|1240|Incidence|101064898|Hodgkin Lymphoma|2003-2007
10-14|0.6|0.8|0.7|139|Mortality|21098577|Brain and Other Nervous System|2004
<1|~|~|~|~|Mortality|4092369|Kidney and Renal Pelvis|2004
10-14|0.1|0.2|0.2|38|Incidence|21098577|Kidney and Renal Pelvis|2004
15-19|2.9|3.4|3.2|675|Mortality|21246129|All Cancer Sites Combined|2006
10-14|13.0|13.4|13.2|13315|Incidence|101064898|All Cancer Sites Combined|2003-2007
1-4|1.8|2.3|2.0|325|Incidence|15966362|Kidney and Renal Pelvis|2004
5-9|0.1|0.2|0.1|22|Mortality|19579623|Non-Hodgkin Lymphoma|2004
15-19|~|~|~|~|Mortality|20993786|Kidney and Renal Pelvis|2005
5-9|0.4|0.6|0.5|99|Incidence|19505775|Kidney and Renal Pelvis|2005
1-4|0.0|0.0|0.0|25|Mortality|80636900|Non-Hodgkin Lymphoma|2003-2007
15-19|0.2|0.3|0.2|248|Mortality|104809251|Non-Hodgkin Lymphoma|2003-2007
1-4|~|~|~|~|Incidence|15966362|Hodgkin Lymphoma|2004
10-14|1.0|1.3|1.2|243|Incidence|21098577|Hodgkin Lymphoma|2004
<1|~|~|~|~|Incidence|4092369|Hodgkin Lymphoma|2004
<1|1.4|2.3|1.8|74|Mortality|4092369|All Cancer Sites Combined|2004
<1|3.4|4.7|4.0|164|Incidence|4092369|Brain and Other Nervous System|2004
15-19|0.4|0.6|0.5|109|Mortality|20677486|Brain and Other Nervous System|2004
1-4|0.6|0.7|0.6|500|Incidence|78339910|Non-Hodgkin Lymphoma|2003-2007
5-9|3.2|3.7|3.5|681|Incidence|19579623|Brain and Other Nervous System|2004
<1|~|~|~|~|Mortality|20659486|Hodgkin Lymphoma|2003-2007
15-19|0.0|0.1|0.0|49|Mortality|104809251|Kidney and Renal Pelvis|2003-2007
<1|~|~|~|~|Mortality|4092369|Hodgkin Lymphoma|2004
15-19|3.0|3.5|3.2|663|Incidence|20677486|Hodgkin Lymphoma|2004
5-9|0.3|0.4|0.4|69|Incidence|19579623|Hodgkin Lymphoma|2004
1-4|0.5|0.8|0.7|106|Incidence|15966362|Non-Hodgkin Lymphoma|2004
1-4|~|~|~|~|Mortality|16199802|Non-Hodgkin Lymphoma|2005
15-19|3.3|3.8|3.6|723|Mortality|20346043|All Cancer Sites Combined|2002
5-9|0.8|1.1|1.0|188|Mortality|19505775|Brain and Other Nervous System|2005
10-14|2.3|2.7|2.5|515|Mortality|20823279|All Cancer Sites Combined|2005
5-9|2.3|2.7|2.5|485|Mortality|19505775|All Cancer Sites Combined|2005
<1|22.7|25.8|24.2|993|Incidence|4101644|All Cancer Sites Combined|2005
1-4|3.8|4.4|4.1|662|Incidence|16199802|Brain and Other Nervous System|2005
<1|~|~|~|~|Mortality|4092369|Non-Hodgkin Lymphoma|2004
10-14|2.5|2.9|2.7|572|Incidence|21098577|Brain and Other Nervous System|2004
<1|~|~|~|~|Mortality|3985649|Non-Hodgkin Lymphoma|2002
5-9|0.8|1.0|0.9|176|Mortality|19654941|Brain and Other Nervous System|2006
15-19|2.1|2.5|2.3|486|Incidence|21246129|Brain and Other Nervous System|2006
10-14|~|~|~|~|Mortality|21098045|Kidney and Renal Pelvis|2002
1-4|2.0|2.5|2.2|364|Mortality|16456673|All Cancer Sites Combined|2007
15-19|3.2|3.7|3.5|731|Mortality|20993786|All Cancer Sites Combined|2005
10-14|~|~|~|~|Mortality|21098577|Hodgkin Lymphoma|2004
15-19|2.0|2.4|2.2|464|Incidence|20993786|Brain and Other Nervous System|2005
<1|2.9|4.1|3.4|141|Incidence|4101644|Brain and Other Nervous System|2005
<1|3.3|4.6|3.9|166|Incidence|4233070|Brain and Other Nervous System|2007
1-4|0.1|0.2|0.1|16|Incidence|16275937|Hodgkin Lymphoma|2006
5-9|0.1|0.2|0.1|23|Mortality|19654941|Kidney and Renal Pelvis|2006
10-14|0.5|0.8|0.7|136|Mortality|20823279|Brain and Other Nervous System|2005
10-14|0.1|0.2|0.1|24|Incidence|20562276|Kidney and Renal Pelvis|2006
<1|0.3|0.7|0.4|18|Mortality|4101644|Brain and Other Nervous System|2005
1-4|0.1|0.2|0.1|18|Mortality|15966362|Kidney and Renal Pelvis|2004
10-14|1.1|1.5|1.3|270|Incidence|20823279|Hodgkin Lymphoma|2005
15-19|3.1|3.6|3.3|703|Incidence|20993786|Hodgkin Lymphoma|2005
<1|1.3|2.1|1.7|70|Incidence|4233070|Kidney and Renal Pelvis|2007
5-9|2.4|2.8|2.6|516|Mortality|19737870|All Cancer Sites Combined|2003
1-4|19.9|21.3|20.6|3181|Incidence|15428404|All Cancer Sites Combined|2003
10-14|2.5|2.9|2.7|561|Incidence|20766925|Brain and Other Nervous System|2003
1-4|1.8|2.2|2.0|322|Incidence|16199802|Kidney and Renal Pelvis|2005
15-19|0.2|0.3|0.2|47|Mortality|20993786|Non-Hodgkin Lymphoma|2005
5-9|~|~|~|~|Mortality|19505775|Hodgkin Lymphoma|2005
<1|~|~|~|~|Incidence|4101644|Hodgkin Lymphoma|2005
10-14|~|~|~|~|Mortality|20823279|Kidney and Renal Pelvis|2005
5-9|0.1|0.2|0.1|20|Mortality|19505775|Kidney and Renal Pelvis|2005
<1|1.2|2.0|1.6|65|Incidence|4101644|Kidney and Renal Pelvis|2005
5-9|0.1|0.2|0.1|19|Mortality|19505775|Non-Hodgkin Lymphoma|2005
5-9|0.7|1.0|0.9|170|Incidence|19505775|Non-Hodgkin Lymphoma|2005
1-4|0.5|0.7|0.6|93|Incidence|16275937|Non-Hodgkin Lymphoma|2006
<1|~|~|~|~|Mortality|4032152|Kidney and Renal Pelvis|2003
1-4|1.8|2.2|2.0|309|Incidence|15428404|Kidney and Renal Pelvis|2003
10-14|0.1|0.2|0.2|33|Incidence|20766925|Kidney and Renal Pelvis|2003
10-14|0.1|0.1|0.1|19|Mortality|21098577|Non-Hodgkin Lymphoma|2004
15-19|0.2|0.4|0.3|56|Mortality|20677486|Non-Hodgkin Lymphoma|2004
<1|~|~|~|~|Mortality|4273543|Non-Hodgkin Lymphoma|2007
1-4|0.5|0.8|0.6|105|Incidence|16199802|Non-Hodgkin Lymphoma|2005
<1|~|~|~|~|Incidence|4101644|Non-Hodgkin Lymphoma|2005
10-14|1.1|1.5|1.3|265|Incidence|20562276|Hodgkin Lymphoma|2006
1-4|0.1|0.2|0.1|16|Mortality|16199802|Kidney and Renal Pelvis|2005
10-14|12.5|13.5|13.0|2708|Incidence|20823279|All Cancer Sites Combined|2005
5-9|0.7|1.0|0.9|172|Mortality|19836930|Brain and Other Nervous System|2007
<1|~|~|~|~|Incidence|4092369|Non-Hodgkin Lymphoma|2004
15-19|2.1|2.5|2.3|479|Incidence|21283988|Brain and Other Nervous System|2007
15-19|1.8|2.1|1.9|408|Incidence|20993786|Non-Hodgkin Lymphoma|2005
1-4|0.4|0.6|0.5|84|Mortality|16199802|Brain and Other Nervous System|2005
1-4|19.6|21.0|20.3|3309|Incidence|16275937|All Cancer Sites Combined|2006
<1|~|~|~|~|Mortality|4159778|Kidney and Renal Pelvis|2006
10-14|0.5|0.7|0.6|129|Mortality|20562276|Brain and Other Nervous System|2006
5-9|~|~|~|~|Mortality|19836930|Hodgkin Lymphoma|2007
1-4|~|~|~|~|Incidence|16301645|Hodgkin Lymphoma|2007
<1|~|~|~|~|Incidence|4233070|Hodgkin Lymphoma|2007
5-9|0.4|0.7|0.5|106|Incidence|19654941|Kidney and Renal Pelvis|2006
<1|3.0|4.2|3.6|148|Incidence|4159778|Brain and Other Nervous System|2006
5-9|2.1|2.6|2.3|459|Mortality|19654941|All Cancer Sites Combined|2006
<1|~|~|~|~|Mortality|4101644|Kidney and Renal Pelvis|2005
<1|1.4|2.3|1.8|76|Mortality|4159778|All Cancer Sites Combined|2006
15-19|20.9|22.2|21.6|4580|Incidence|21246129|All Cancer Sites Combined|2006
10-14|0.1|0.2|0.1|25|Mortality|20562276|Non-Hodgkin Lymphoma|2006
5-9|0.8|1.0|0.9|174|Incidence|19654941|Non-Hodgkin Lymphoma|2006
1-4|~|~|~|~|Mortality|16456673|Non-Hodgkin Lymphoma|2007
1-4|0.5|0.7|0.6|92|Incidence|16301645|Non-Hodgkin Lymphoma|2007
10-14|1.2|1.5|1.4|273|Incidence|20114445|Non-Hodgkin Lymphoma|2007
<1|0.3|0.7|0.4|19|Incidence|4233070|Non-Hodgkin Lymphoma|2007
1-4|~|~|~|~|Mortality|16275937|Non-Hodgkin Lymphoma|2006
1-4|4.1|4.4|4.2|3316|Incidence|78339910|Brain and Other Nervous System|2003-2007
<1|24.3|27.5|25.9|1076|Incidence|4159778|All Cancer Sites Combined|2006
10-14|2.2|2.6|2.4|479|Mortality|20291912|All Cancer Sites Combined|2007
15-19|0.2|0.3|0.2|48|Incidence|21246129|Kidney and Renal Pelvis|2006
15-19|21.2|22.4|21.8|4641|Incidence|21283988|All Cancer Sites Combined|2007
<1|1.3|2.1|1.7|72|Mortality|4273543|All Cancer Sites Combined|2007
<1|23.4|26.5|24.9|1055|Incidence|4233070|All Cancer Sites Combined|2007
1-4|0.1|0.1|0.1|68|Mortality|80636900|Kidney and Renal Pelvis|2003-2007
5-9|0.3|0.4|0.4|69|Incidence|19657805|Hodgkin Lymphoma|2007
10-14|0.1|0.2|0.1|147|Incidence|101064898|Kidney and Renal Pelvis|2003-2007
5-9|~|~|~|~|Mortality|19654941|Non-Hodgkin Lymphoma|2006
15-19|~|~|~|~|Mortality|21445610|Kidney and Renal Pelvis|2007
5-9|~|~|~|~|Mortality|19654941|Hodgkin Lymphoma|2006
<1|~|~|~|~|Mortality|4159778|Hodgkin Lymphoma|2006
10-14|0.6|0.9|0.8|161|Mortality|21178064|Brain and Other Nervous System|2003
15-19|0.5|0.7|0.6|119|Mortality|20446240|Brain and Other Nervous System|2003
5-9|0.8|1.0|0.9|175|Mortality|19737870|Brain and Other Nervous System|2003
10-14|~|~|~|~|Mortality|20562276|Kidney and Renal Pelvis|2006
15-19|2.0|2.4|2.2|440|Incidence|20061631|Brain and Other Nervous System|2003
1-4|2.1|2.6|2.3|377|Mortality|16275937|All Cancer Sites Combined|2006
10-14|12.9|13.9|13.4|2751|Incidence|20562276|All Cancer Sites Combined|2006
1-4|~|~|~|~|Mortality|16456673|Kidney and Renal Pelvis|2007
10-14|~|~|~|~|Mortality|20562276|Hodgkin Lymphoma|2006
5-9|0.4|0.6|0.5|90|Incidence|19654941|Hodgkin Lymphoma|2006
5-9|0.3|0.5|0.4|76|Incidence|19505775|Hodgkin Lymphoma|2005
1-4|1.8|2.2|2.0|319|Incidence|16275937|Kidney and Renal Pelvis|2006
15-19|0.2|0.3|0.2|45|Mortality|21246129|Non-Hodgkin Lymphoma|2006
1-4|20.4|21.8|21.1|3444|Incidence|16301645|All Cancer Sites Combined|2007
5-9|11.4|12.4|11.9|2335|Incidence|19657805|All Cancer Sites Combined|2007
15-19|1.7|1.8|1.8|1793|Incidence|102079321|Non-Hodgkin Lymphoma|2003-2007
15-19|2.9|3.4|3.1|673|Mortality|21445610|All Cancer Sites Combined|2007
1-4|3.8|4.5|4.1|675|Incidence|16301645|Brain and Other Nervous System|2007
5-9|3.1|3.6|3.4|659|Incidence|19657805|Brain and Other Nervous System|2007
15-19|3.0|3.5|3.2|683|Incidence|21283988|Hodgkin Lymphoma|2007
<1|~|~|~|~|Mortality|4273543|Kidney and Renal Pelvis|2007
1-4|~|~|~|~|Mortality|15738126|Kidney and Renal Pelvis|2003
10-14|0.1|0.2|0.1|20|Mortality|20291912|Non-Hodgkin Lymphoma|2007
5-9|0.9|1.2|1.0|200|Incidence|19657805|Non-Hodgkin Lymphoma|2007
15-19|21.2|22.4|21.8|4505|Incidence|20677486|All Cancer Sites Combined|2004
10-14|1.0|1.4|1.2|240|Incidence|20114445|Hodgkin Lymphoma|2007
15-19|0.0|0.1|0.1|16|Mortality|21445610|Hodgkin Lymphoma|2007
<1|~|~|~|~|Mortality|4273543|Hodgkin Lymphoma|2007
1-4|1.7|2.1|1.9|307|Incidence|16301645|Kidney and Renal Pelvis|2007
10-14|0.1|0.2|0.2|31|Incidence|20114445|Kidney and Renal Pelvis|2007
10-14|1.0|1.4|1.2|218|Incidence|18331872|Non-Hodgkin Lymphoma|1999
5-9|0.8|1.1|0.9|184|Incidence|19579623|Non-Hodgkin Lymphoma|2004
15-19|0.2|0.3|0.2|47|Mortality|21445610|Non-Hodgkin Lymphoma|2007
<1|1.4|2.3|1.8|75|Mortality|4101644|All Cancer Sites Combined|2005
5-9|~|~|~|~|Mortality|19836930|Non-Hodgkin Lymphoma|2007
15-19|0.2|0.3|0.3|53|Mortality|20446240|Non-Hodgkin Lymphoma|2003
<1|~|~|~|~|Mortality|4032152|Non-Hodgkin Lymphoma|2003
10-14|2.0|2.4|2.2|448|Mortality|20562276|All Cancer Sites Combined|2006
10-14|2.4|2.8|2.6|537|Incidence|20562276|Brain and Other Nervous System|2006
15-19|3.2|3.5|3.3|3500|Mortality|104809251|All Cancer Sites Combined|2003-2007
15-19|21.5|22.1|21.8|22266|Incidence|102079321|All Cancer Sites Combined|2003-2007
15-19|0.5|0.6|0.5|543|Mortality|104809251|Brain and Other Nervous System|2003-2007
15-19|0.4|0.6|0.5|102|Mortality|21246129|Brain and Other Nervous System|2006
1-4|~|~|~|~|Mortality|16275937|Hodgkin Lymphoma|2006
<1|~|~|~|~|Incidence|4159778|Hodgkin Lymphoma|2006
15-19|3.0|3.4|3.2|677|Incidence|21246129|Hodgkin Lymphoma|2006
5-9|0.1|0.1|0.1|111|Mortality|98315139|Kidney and Renal Pelvis|2003-2007
<1|1.3|2.1|1.7|69|Incidence|4159778|Kidney and Renal Pelvis|2006
15-19|0.2|0.3|0.3|51|Mortality|20084602|Non-Hodgkin Lymphoma|1999
5-9|0.1|0.1|0.1|82|Mortality|98315139|Non-Hodgkin Lymphoma|2003-2007
10-14|1.2|1.3|1.2|1245|Incidence|101064898|Non-Hodgkin Lymphoma|2003-2007
<1|0.3|0.4|0.4|71|Incidence|20070646|Non-Hodgkin Lymphoma|2003-2007
15-19|1.6|2.0|1.8|377|Incidence|21246129|Non-Hodgkin Lymphoma|2006
<1|0.3|0.7|0.5|20|Incidence|4159778|Non-Hodgkin Lymphoma|2006
10-14|0.5|0.8|0.6|130|Mortality|20291912|Brain and Other Nervous System|2007
10-14|~|~|~|~|Mortality|20291912|Hodgkin Lymphoma|2007
5-9|0.5|0.7|0.6|120|Incidence|19657805|Kidney and Renal Pelvis|2007
15-19|1.5|1.9|1.7|357|Incidence|21283988|Non-Hodgkin Lymphoma|2007
10-14|~|~|~|~|Mortality|20618738|Hodgkin Lymphoma|2000
15-19|3.3|3.8|3.5|731|Mortality|20677486|All Cancer Sites Combined|2004
15-19|2.1|2.5|2.3|474|Incidence|20677486|Brain and Other Nervous System|2004
10-14|~|~|~|~|Mortality|21098577|Kidney and Renal Pelvis|2004
1-4|~|~|~|~|Mortality|15966362|Non-Hodgkin Lymphoma|2004
10-14|1.1|1.5|1.3|273|Incidence|21098577|Non-Hodgkin Lymphoma|2004
15-19|19.9|21.2|20.5|3762|Incidence|18341898|All Cancer Sites Combined|2000
15-19|0.5|0.7|0.6|118|Mortality|20993786|Brain and Other Nervous System|2005
10-14|0.1|0.2|0.1|27|Incidence|20823279|Kidney and Renal Pelvis|2005
15-19|2.0|2.4|2.2|401|Incidence|18341898|Brain and Other Nervous System|2000
10-14|12.7|13.7|13.2|2606|Incidence|19760108|All Cancer Sites Combined|2001
<1|23.3|26.5|24.9|948|Incidence|3806227|All Cancer Sites Combined|2001
15-19|0.4|0.6|0.5|104|Mortality|20297606|Brain and Other Nervous System|2001
1-4|3.6|4.3|3.9|568|Incidence|14487799|Brain and Other Nervous System|2001
1-4|1.9|2.3|2.1|303|Incidence|14487799|Kidney and Renal Pelvis|2001
15-19|0.1|0.2|0.1|21|Mortality|20259270|Hodgkin Lymphoma|2000
10-14|0.1|0.2|0.1|27|Mortality|20887927|Non-Hodgkin Lymphoma|2001
15-19|0.2|0.4|0.3|61|Mortality|20297606|Non-Hodgkin Lymphoma|2001
1-4|~|~|~|~|Mortality|16275937|Kidney and Renal Pelvis|2006
5-9|3.3|3.9|3.6|675|Incidence|18856401|Brain and Other Nervous System|2002
10-14|1.1|1.4|1.2|254|Incidence|20562276|Non-Hodgkin Lymphoma|2006
1-4|~|~|~|~|Mortality|15548021|Non-Hodgkin Lymphoma|2002
1-4|0.5|0.8|0.7|109|Mortality|16456673|Brain and Other Nervous System|2007
5-9|0.8|1.1|1.0|181|Incidence|18856401|Non-Hodgkin Lymphoma|2002
<1|23.3|26.4|24.8|982|Incidence|3954649|All Cancer Sites Combined|2003
10-14|0.9|1.2|1.0|214|Incidence|20766925|Non-Hodgkin Lymphoma|2003
5-9|0.9|1.2|1.1|200|Incidence|18571375|Non-Hodgkin Lymphoma|2000
5-9|11.4|11.9|11.6|11124|Incidence|95517738|All Cancer Sites Combined|2003-2007
<1|24.3|25.7|25.0|5018|Incidence|20070646|All Cancer Sites Combined|2003-2007
15-19|0.2|0.2|0.2|198|Incidence|102079321|Kidney and Renal Pelvis|2003-2007
1-4|2.3|2.8|2.5|399|Mortality|15966362|All Cancer Sites Combined|2004
5-9|11.3|12.2|11.8|2301|Incidence|19579623|All Cancer Sites Combined|2004
1-4|0.5|0.8|0.6|102|Mortality|15966362|Brain and Other Nervous System|2004
5-9|2.2|2.7|2.4|493|Mortality|20229583|All Cancer Sites Combined|2001
10-14|0.5|0.7|0.6|130|Mortality|20887927|Brain and Other Nervous System|2001
<1|0.2|0.6|0.4|16|Mortality|4026137|Brain and Other Nervous System|2001
1-4|20.2|21.6|20.9|3386|Incidence|16199802|All Cancer Sites Combined|2005
5-9|11.1|12.0|11.5|2250|Incidence|19505775|All Cancer Sites Combined|2005
1-4|0.1|0.2|0.1|20|Incidence|14487799|Hodgkin Lymphoma|2001
5-9|3.0|3.5|3.3|640|Incidence|19505775|Brain and Other Nervous System|2005
10-14|~|~|~|~|Mortality|20887927|Kidney and Renal Pelvis|2001
10-14|1.1|1.4|1.2|259|Incidence|20823279|Non-Hodgkin Lymphoma|2005
5-9|11.2|12.2|11.7|2304|Incidence|19654941|All Cancer Sites Combined|2006
1-4|4.0|4.7|4.3|703|Incidence|16275937|Brain and Other Nervous System|2006
5-9|3.0|3.5|3.2|632|Incidence|19654941|Brain and Other Nervous System|2006
<1|~|~|~|~|Mortality|4159778|Non-Hodgkin Lymphoma|2006
1-4|0.5|0.7|0.6|84|Incidence|14487799|Non-Hodgkin Lymphoma|2001
5-9|0.8|1.1|0.9|178|Incidence|19141933|Non-Hodgkin Lymphoma|2001
5-9|2.2|2.6|2.4|480|Mortality|19836930|All Cancer Sites Combined|2007
10-14|2.6|3.0|2.8|563|Incidence|20114445|Brain and Other Nervous System|2007
<1|1.5|2.3|1.9|74|Mortality|3985649|All Cancer Sites Combined|2002
5-9|0.3|0.4|0.3|63|Incidence|18856401|Hodgkin Lymphoma|2002
10-14|2.4|2.9|2.6|560|Mortality|21178064|All Cancer Sites Combined|2003
10-14|2.6|2.8|2.7|2708|Incidence|101064898|Brain and Other Nervous System|2003-2007
5-9|3.2|3.4|3.3|3167|Incidence|95517738|Brain and Other Nervous System|2003-2007
<1|3.5|4.0|3.7|751|Incidence|20070646|Brain and Other Nervous System|2003-2007
10-14|0.0|0.1|0.0|42|Mortality|103954108|Kidney and Renal Pelvis|2003-2007
<1|23.7|26.8|25.2|1033|Incidence|4092369|All Cancer Sites Combined|2004
15-19|21.6|22.9|22.3|4674|Incidence|20993786|All Cancer Sites Combined|2005
1-4|~|~|~|~|Mortality|16199802|Hodgkin Lymphoma|2005
15-19|0.1|0.1|0.1|18|Mortality|21246129|Hodgkin Lymphoma|2006
15-19|~|~|~|~|Mortality|21246129|Kidney and Renal Pelvis|2006
<1|~|~|~|~|Mortality|4273543|Brain and Other Nervous System|2007
1-4|~|~|~|~|Mortality|16456673|Hodgkin Lymphoma|2007
15-19|0.1|0.3|0.2|43|Incidence|21283988|Kidney and Renal Pelvis|2007
10-14|2.3|2.8|2.5|525|Mortality|20618738|All Cancer Sites Combined|2000
10-14|0.1|0.2|0.2|30|Incidence|19760108|Kidney and Renal Pelvis|2001
15-19|20.9|22.3|21.6|4148|Incidence|19203368|All Cancer Sites Combined|2002
5-9|11.6|12.6|12.1|2273|Incidence|18856401|All Cancer Sites Combined|2002
<1|~|~|~|~|Incidence|3761784|Hodgkin Lymphoma|2002
15-19|~|~|~|~|Mortality|20346043|Kidney and Renal Pelvis|2002
1-4|0.6|0.8|0.7|102|Incidence|14671443|Non-Hodgkin Lymphoma|2002
10-14|12.4|13.4|12.9|2675|Incidence|20766925|All Cancer Sites Combined|2003
1-4|0.5|0.8|0.7|104|Mortality|15738126|Brain and Other Nervous System|2003
<1|~|~|~|~|Mortality|4032152|Hodgkin Lymphoma|2003
10-14|1.1|1.4|1.2|248|Incidence|20766925|Hodgkin Lymphoma|2003
1-4|0.6|0.7|0.6|500|Mortality|80636900|Brain and Other Nervous System|2003-2007
5-9|0.9|1.0|0.9|897|Mortality|98315139|Brain and Other Nervous System|2003-2007
15-19|0.1|0.3|0.2|39|Incidence|20677486|Kidney and Renal Pelvis|2004
1-4|2.1|2.6|2.3|377|Mortality|16199802|All Cancer Sites Combined|2005
10-14|0.1|0.2|0.1|29|Mortality|20823279|Non-Hodgkin Lymphoma|2005
<1|~|~|~|~|Mortality|4101644|Non-Hodgkin Lymphoma|2005
1-4|0.5|0.8|0.6|101|Mortality|16275937|Brain and Other Nervous System|2006
<1|0.2|0.6|0.4|16|Mortality|4159778|Brain and Other Nervous System|2006
10-14|12.6|13.7|13.1|2644|Incidence|20114445|All Cancer Sites Combined|2007
15-19|0.4|0.5|0.4|95|Mortality|21445610|Brain and Other Nervous System|2007
10-14|~|~|~|~|Mortality|20291912|Kidney and Renal Pelvis|2007
5-9|0.0|0.1|0.1|17|Mortality|19836930|Kidney and Renal Pelvis|2007
15-19|1.4|1.8|1.6|292|Incidence|18341898|Acute Lymphocytic|2000
<1|~|~|~|~|Mortality|3855509|Acute Myeloid|2000
<1|~|~|~|~|Mortality|4026137|Acute Myeloid|2001
10-14|0.6|0.8|0.7|131|Incidence|19760108|Acute Myeloid|2001
<1|0.4|0.9|0.6|25|Mortality|4026137|Leukemia|2001
1-4|0.1|0.2|0.1|18|Mortality|15322194|Soft Tissue|2001
5-9|0.1|0.2|0.1|26|Mortality|20229583|Soft Tissue|2001
15-19|0.3|0.5|0.4|78|Mortality|20346043|Acute Myeloid|2002
<1|~|~|~|~|Incidence|3761784|Bones and Joints|2002
<1|~|~|~|~|Mortality|3985649|Soft Tissue|2002
<1|~|~|~|~|Mortality|4032152|Acute Lymphocytic|2003
15-19|0.7|0.9|0.8|160|Incidence|20061631|Acute Myeloid|2003
10-14|0.8|1.0|0.9|186|Mortality|21178064|Leukemia|2003
15-19|0.6|0.8|0.7|136|Mortality|20446240|Other|2003
10-14|0.3|0.4|0.4|387|Mortality|103954108|Acute Lymphocytic|2003-2007
<1|~|~|~|~|Mortality|20659486|Bones and Joints|2003-2007
5-9|3.0|3.5|3.2|629|Incidence|19579623|Acute Lymphocytic|2004
10-14|0.2|0.3|0.2|50|Mortality|21098577|Acute Myeloid|2004
5-9|0.4|0.6|0.5|90|Incidence|19579623|Acute Myeloid|2004
15-19|0.2|0.4|0.3|66|Mortality|20677486|Soft Tissue|2004
1-4|0.9|1.2|1.1|171|Incidence|15966362|Soft Tissue|2004
10-14|0.3|0.5|0.4|79|Mortality|20823279|Acute Lymphocytic|2005
<1|~|~|~|~|Mortality|4101644|Bones and Joints|2005
1-4|0.9|1.2|1.0|169|Incidence|16199802|Soft Tissue|2005
5-9|0.5|0.8|0.6|124|Incidence|19505775|Soft Tissue|2005
15-19|0.3|0.5|0.4|92|Mortality|21246129|Acute Lymphocytic|2006
5-9|0.1|0.1|0.1|17|Mortality|19654941|Acute Myeloid|2006
10-14|0.2|0.3|0.3|52|Mortality|20291912|Acute Myeloid|2007
<1|1.0|1.7|1.3|54|Incidence|4233070|Acute Myeloid|2007
1-4|0.9|1.3|1.1|176|Incidence|16301645|Soft Tissue|2007
<1|~|~|~|~|Mortality|3795762|Acute Lymphocytic|1999
10-14|0.3|0.4|0.3|68|Mortality|20213364|Other|1999
5-9|0.5|0.7|0.6|106|Incidence|18696975|Soft Tissue|1999
5-9|0.1|0.2|0.2|33|Mortality|20474990|Acute Myeloid|2000
10-14|0.7|1.0|0.8|173|Mortality|20618738|Leukemia|2000
5-9|0.4|0.6|0.5|98|Mortality|20474990|Other|2000
<1|0.4|0.9|0.6|24|Mortality|3855509|Other|2000
5-9|2.8|3.3|3.1|591|Incidence|19141933|Acute Lymphocytic|2001
<1|10.6|12.8|11.7|444|Incidence|3806227|Other|2001
10-14|0.7|1.0|0.9|170|Incidence|19760108|Soft Tissue|2001
<1|0.9|1.7|1.2|47|Incidence|3761784|Acute Myeloid|2002
15-19|1.0|1.3|1.2|237|Mortality|20346043|Leukemia|2002
1-4|0.2|0.3|0.2|38|Mortality|15738126|Acute Myeloid|2003
<1|~|~|~|~|Mortality|4032152|Soft Tissue|2003
15-19|8.6|9.0|8.8|8980|Incidence|102079321|Other|2003-2007
5-9|1.4|1.6|1.5|1417|Incidence|95517738|Other|2003-2007
15-19|0.3|0.4|0.3|332|Mortality|104809251|Soft Tissue|2003-2007
<1|0.1|0.1|0.1|20|Mortality|20659486|Soft Tissue|2003-2007
<1|~|~|~|~|Mortality|4092369|Bones and Joints|2004
1-4|0.1|0.3|0.2|31|Incidence|15966362|Bones and Joints|2004
15-19|8.5|9.3|8.9|1831|Incidence|20677486|Other|2004
1-4|0.1|0.2|0.2|24|Mortality|15966362|Soft Tissue|2004
15-19|1.4|1.7|1.6|326|Incidence|20993786|Acute Lymphocytic|2005
5-9|0.3|0.5|0.4|74|Incidence|19505775|Acute Myeloid|2005
5-9|0.5|0.8|0.6|125|Mortality|19505775|Leukemia|2005
<1|0.3|0.8|0.5|22|Mortality|4101644|Leukemia|2005
<1|0.3|0.7|0.5|19|Mortality|4101644|Other|2005
10-14|0.1|0.2|0.2|35|Mortality|20823279|Soft Tissue|2005
<1|~|~|~|~|Mortality|4159778|Acute Lymphocytic|2006
1-4|0.6|0.9|0.8|124|Mortality|16275937|Leukemia|2006
<1|4.0|5.3|4.6|192|Incidence|4159778|Leukemia|2006
15-19|0.3|0.5|0.4|82|Mortality|21445610|Acute Lymphocytic|2007
10-14|1.1|1.5|1.3|262|Incidence|20114445|Bones and Joints|2007
5-9|1.3|1.6|1.4|278|Incidence|19657805|Other|2007
1-4|0.1|0.2|0.1|17|Mortality|16456673|Soft Tissue|2007
10-14|0.7|0.9|0.8|157|Incidence|20114445|Soft Tissue|2007
<1|2.8|4.0|3.4|142|Incidence|4233070|Soft Tissue|2007
15-19|0.3|0.4|0.3|66|Mortality|20084602|Acute Myeloid|1999
15-19|0.7|1.0|0.9|159|Incidence|18177976|Acute Myeloid|1999
1-4|~|~|~|~|Mortality|15339782|Bones and Joints|1999
10-14|1.3|1.6|1.5|266|Incidence|18331872|Bones and Joints|1999
<1|~|~|~|~|Incidence|3432436|Bones and Joints|1999
10-14|0.7|1.0|0.9|175|Mortality|20213364|Leukemia|1999
<1|0.4|0.9|0.6|23|Mortality|3795762|Other|1999
5-9|2.9|3.4|3.2|591|Incidence|18571375|Acute Lymphocytic|2000
<1|1.9|3.0|2.4|83|Incidence|3485395|Acute Lymphocytic|2000
10-14|0.4|0.6|0.5|86|Incidence|18696519|Acute Myeloid|2000
1-4|0.8|1.1|0.9|137|Mortality|15330856|Leukemia|2000
1-4|0.7|1.0|0.9|135|Mortality|15330856|Other|2000
1-4|3.6|4.3|4.0|551|Incidence|13887421|Other|2000
1-4|7.2|8.1|7.6|1105|Incidence|14487799|Acute Lymphocytic|2001
1-4|0.4|0.6|0.5|73|Mortality|15322194|Acute Myeloid|2001
10-14|0.7|0.9|0.8|170|Mortality|20887927|Leukemia|2001
1-4|4.2|4.9|4.5|654|Incidence|14487799|Other|2001
15-19|0.9|1.2|1.1|207|Incidence|19191395|Soft Tissue|2001
10-14|0.6|0.8|0.7|134|Incidence|19925443|Acute Myeloid|2002
1-4|~|~|~|~|Mortality|15548021|Bones and Joints|2002
10-14|2.4|2.8|2.6|519|Incidence|19925443|Other|2002
<1|2.6|3.8|3.1|118|Incidence|3761784|Soft Tissue|2002
1-4|0.3|0.5|0.4|61|Mortality|15738126|Acute Lymphocytic|2003
<1|10.4|12.6|11.5|454|Incidence|3954649|Other|2003
15-19|0.3|0.4|0.3|68|Mortality|20446240|Soft Tissue|2003
<1|0.4|0.7|0.5|112|Mortality|20659486|Other|2003-2007
5-9|0.1|0.2|0.1|130|Mortality|98315139|Soft Tissue|2003-2007
15-19|1.1|1.3|1.2|1221|Incidence|102079321|Soft Tissue|2003-2007
<1|~|~|~|~|Mortality|4092369|Acute Myeloid|2004
15-19|0.7|1.0|0.9|176|Incidence|20677486|Acute Myeloid|2004
1-4|0.6|0.9|0.8|120|Mortality|15966362|Leukemia|2004
10-14|0.1|0.3|0.2|42|Mortality|21098577|Soft Tissue|2004
10-14|0.8|1.1|1.0|203|Incidence|21098577|Soft Tissue|2004
1-4|0.7|1.0|0.8|137|Incidence|16199802|Acute Myeloid|2005
10-14|0.6|0.8|0.7|150|Mortality|20823279|Leukemia|2005
<1|0.9|1.6|1.2|50|Incidence|4159778|Acute Myeloid|2006
15-19|0.4|0.6|0.5|115|Mortality|21246129|Bones and Joints|2006
<1|0.5|1.1|0.7|31|Mortality|4159778|Leukemia|2006
15-19|0.5|0.7|0.6|117|Mortality|21246129|Other|2006
5-9|0.4|0.6|0.5|96|Mortality|19654941|Other|2006
10-14|2.6|3.0|2.8|572|Incidence|20562276|Other|2006
5-9|1.4|1.8|1.6|315|Incidence|19654941|Other|2006
1-4|0.9|1.3|1.1|178|Incidence|16275937|Soft Tissue|2006
10-14|0.3|0.5|0.4|80|Mortality|20291912|Acute Lymphocytic|2007
1-4|7.1|8.0|7.5|1227|Incidence|16301645|Acute Lymphocytic|2007
10-14|1.7|2.1|1.9|378|Incidence|20114445|Acute Lymphocytic|2007
10-14|2.7|3.1|2.9|581|Incidence|20114445|Leukemia|2007
5-9|0.1|0.2|0.1|24|Mortality|19836930|Soft Tissue|2007
15-19|0.8|1.1|1.0|175|Incidence|18177976|Soft Tissue|1999
10-14|0.4|0.5|0.4|92|Mortality|20618738|Acute Lymphocytic|2000
10-14|0.2|0.3|0.2|47|Mortality|20618738|Acute Myeloid|2000
5-9|0.5|0.7|0.6|107|Incidence|18571375|Soft Tissue|2000
<1|2.6|3.8|3.1|109|Incidence|3485395|Soft Tissue|2000
10-14|0.3|0.5|0.4|78|Mortality|20887927|Acute Lymphocytic|2001
15-19|0.7|1.0|0.8|157|Incidence|19191395|Acute Myeloid|2001
<1|~|~|~|~|Mortality|4026137|Bones and Joints|2001
5-9|0.4|0.6|0.5|88|Incidence|19141933|Soft Tissue|2001
15-19|0.4|0.6|0.5|106|Mortality|20346043|Acute Lymphocytic|2002
1-4|0.1|0.3|0.2|26|Incidence|14671443|Bones and Joints|2002
<1|9.9|12.1|11.0|413|Incidence|3761784|Other|2002
5-9|0.1|0.2|0.1|28|Mortality|19965243|Soft Tissue|2002
5-9|0.1|0.3|0.2|39|Mortality|19737870|Acute Myeloid|2003
10-14|2.7|3.2|2.9|611|Incidence|20766925|Other|2003
15-19|1.5|1.7|1.6|1617|Incidence|102079321|Acute Lymphocytic|2003-2007
1-4|0.3|0.4|0.3|254|Mortality|80636900|Acute Myeloid|2003-2007
1-4|0.2|0.2|0.2|151|Incidence|78339910|Bones and Joints|2003-2007
5-9|0.5|0.6|0.6|542|Incidence|95517738|Bones and Joints|2003-2007
1-4|4.1|4.4|4.2|3322|Incidence|78339910|Other|2003-2007
10-14|1.7|2.1|1.9|393|Incidence|21098577|Acute Lymphocytic|2004
15-19|0.2|0.4|0.3|64|Mortality|20677486|Acute Myeloid|2004
1-4|0.3|0.5|0.4|60|Mortality|16199802|Acute Myeloid|2005
10-14|1.1|1.4|1.3|265|Incidence|20823279|Bones and Joints|2005
5-9|3.4|4.0|3.7|722|Incidence|19505775|Leukemia|2005
5-9|0.2|0.3|0.3|52|Mortality|19654941|Acute Lymphocytic|2006
5-9|0.3|0.5|0.4|77|Incidence|19654941|Acute Myeloid|2006
1-4|~|~|~|~|Mortality|16275937|Bones and Joints|2006
5-9|0.1|0.1|0.1|18|Mortality|19654941|Bones and Joints|2006
5-9|3.5|4.0|3.8|739|Incidence|19654941|Leukemia|2006
1-4|~|~|~|~|Mortality|16456673|Bones and Joints|2007
15-19|0.2|0.3|0.3|58|Mortality|21445610|Soft Tissue|2007
1-4|0.2|0.4|0.3|44|Mortality|15339782|Acute Lymphocytic|1999
15-19|0.5|0.8|0.6|127|Mortality|20084602|Bones and Joints|1999
1-4|3.7|4.3|4.0|553|Incidence|13908887|Other|1999
15-19|7.5|8.3|7.9|1440|Incidence|18177976|Other|1999
1-4|0.1|0.2|0.1|18|Mortality|15339782|Soft Tissue|1999
5-9|0.3|0.5|0.4|78|Mortality|20474990|Acute Lymphocytic|2000
5-9|0.0|0.1|0.1|17|Mortality|20474990|Soft Tissue|2000
5-9|0.5|0.7|0.6|106|Incidence|19141933|Bones and Joints|2001
<1|2.8|3.9|3.3|126|Incidence|3806227|Soft Tissue|2001
10-14|1.6|2.0|1.8|365|Incidence|19925443|Acute Lymphocytic|2002
15-19|0.7|1.0|0.8|163|Incidence|19203368|Acute Myeloid|2002
1-4|0.5|0.8|0.7|104|Mortality|15548021|Leukemia|2002
<1|0.3|0.8|0.5|21|Mortality|3985649|Leukemia|2002
5-9|3.6|4.2|3.9|729|Incidence|18856401|Leukemia|2002
15-19|0.6|0.9|0.7|148|Mortality|20346043|Other|2002
15-19|0.2|0.4|0.3|65|Mortality|20446240|Acute Myeloid|2003
<1|~|~|~|~|Mortality|4032152|Acute Myeloid|2003
5-9|~|~|~|~|Mortality|19737870|Bones and Joints|2003
<1|2.6|3.7|3.1|122|Incidence|3954649|Soft Tissue|2003
10-14|0.6|0.7|0.6|649|Incidence|101064898|Acute Myeloid|2003-2007
15-19|0.9|1.0|1.0|1025|Mortality|104809251|Leukemia|2003-2007
<1|0.5|0.7|0.6|127|Mortality|20659486|Leukemia|2003-2007
<1|4.1|4.7|4.4|879|Incidence|20070646|Leukemia|2003-2007
<1|11.0|12.0|11.5|2311|Incidence|20070646|Other|2003-2007
5-9|0.1|0.2|0.2|35|Mortality|19579623|Acute Myeloid|2004
<1|0.4|0.8|0.6|23|Mortality|4092369|Leukemia|2004
<1|0.3|0.8|0.5|20|Mortality|4092369|Other|2004
10-14|0.2|0.4|0.3|67|Mortality|20823279|Bones and Joints|2005
15-19|1.4|1.7|1.5|321|Incidence|20993786|Bones and Joints|2005
10-14|2.6|3.1|2.9|594|Incidence|20823279|Leukemia|2005
1-4|0.7|0.9|0.8|127|Mortality|16199802|Other|2005
<1|9.7|11.8|10.7|439|Incidence|4101644|Other|2005
10-14|0.6|0.8|0.7|140|Incidence|20562276|Acute Myeloid|2006
5-9|0.6|0.8|0.7|136|Incidence|19654941|Bones and Joints|2006
15-19|0.2|0.4|0.3|60|Mortality|21246129|Soft Tissue|2006
<1|~|~|~|~|Mortality|4159778|Soft Tissue|2006
<1|2.5|3.5|3.0|123|Incidence|4159778|Soft Tissue|2006
1-4|0.2|0.3|0.2|38|Mortality|16456673|Acute Lymphocytic|2007
15-19|0.4|0.6|0.5|91|Mortality|20084602|Acute Lymphocytic|1999
<1|~|~|~|~|Mortality|3795762|Acute Myeloid|1999
10-14|0.2|0.4|0.3|55|Mortality|20213364|Bones and Joints|1999
10-14|0.1|0.3|0.2|37|Mortality|20213364|Soft Tissue|1999
1-4|0.2|0.4|0.3|48|Mortality|15330856|Acute Lymphocytic|2000
5-9|0.6|0.8|0.7|142|Mortality|20474990|Leukemia|2000
1-4|0.7|1.0|0.8|120|Incidence|14487799|Acute Myeloid|2001
1-4|0.2|0.4|0.3|46|Mortality|15548021|Acute Myeloid|2002
5-9|0.1|0.2|0.2|34|Mortality|19965243|Acute Myeloid|2002
5-9|0.6|0.9|0.7|148|Mortality|19965243|Leukemia|2002
5-9|0.7|0.9|0.8|156|Mortality|19737870|Leukemia|2003
10-14|0.3|0.4|0.3|69|Mortality|21178064|Other|2003
5-9|0.1|0.2|0.1|26|Mortality|19737870|Soft Tissue|2003
1-4|0.9|1.3|1.1|166|Incidence|15428404|Soft Tissue|2003
15-19|1.1|1.4|1.2|246|Incidence|20061631|Soft Tissue|2003
15-19|0.4|0.4|0.4|428|Mortality|104809251|Acute Lymphocytic|2003-2007
5-9|0.1|0.2|0.1|147|Mortality|98315139|Acute Myeloid|2003-2007
<1|0.1|0.2|0.2|35|Mortality|20659486|Acute Myeloid|2003-2007
10-14|0.8|0.9|0.9|868|Incidence|101064898|Soft Tissue|2003-2007
15-19|1.5|1.8|1.6|335|Incidence|20677486|Acute Lymphocytic|2004
10-14|0.5|0.8|0.6|135|Incidence|21098577|Acute Myeloid|2004
<1|~|~|~|~|Incidence|4092369|Bones and Joints|2004
5-9|0.4|0.6|0.5|98|Mortality|19579623|Other|2004
5-9|0.1|0.2|0.1|28|Mortality|19579623|Soft Tissue|2004
<1|2.6|3.7|3.2|129|Incidence|4092369|Soft Tissue|2004
1-4|6.8|7.6|7.2|1162|Incidence|16199802|Acute Lymphocytic|2005
10-14|0.2|0.3|0.2|44|Mortality|20823279|Acute Myeloid|2005
<1|~|~|~|~|Incidence|4101644|Bones and Joints|2005
15-19|0.3|0.5|0.4|80|Mortality|20993786|Soft Tissue|2005
<1|0.4|0.9|0.6|24|Mortality|4159778|Other|2006
5-9|0.3|0.5|0.4|85|Mortality|19836930|Acute Lymphocytic|2007
<1|1.4|2.3|1.8|77|Incidence|4233070|Acute Lymphocytic|2007
10-14|0.7|1.0|0.9|175|Mortality|20291912|Leukemia|2007
5-9|0.6|0.8|0.7|139|Mortality|19836930|Leukemia|2007
10-14|0.3|0.5|0.4|75|Mortality|20213364|Acute Lymphocytic|1999
<1|1.7|2.7|2.2|75|Incidence|3432436|Acute Lymphocytic|1999
1-4|0.2|0.4|0.3|50|Mortality|15339782|Acute Myeloid|1999
5-9|0.1|0.2|0.1|24|Mortality|20606460|Bones and Joints|1999
15-19|0.2|0.4|0.3|65|Mortality|20084602|Soft Tissue|1999
1-4|0.3|0.5|0.4|56|Mortality|15330856|Acute Myeloid|2000
<1|1.0|1.8|1.3|47|Incidence|3485395|Acute Myeloid|2000
15-19|0.4|0.6|0.5|98|Mortality|20259270|Bones and Joints|2000
<1|~|~|~|~|Mortality|3855509|Bones and Joints|2000
15-19|1.3|1.6|1.4|260|Incidence|18341898|Bones and Joints|2000
15-19|0.3|0.5|0.4|73|Mortality|20259270|Soft Tissue|2000
10-14|0.7|1.0|0.8|155|Incidence|18696519|Soft Tissue|2000
5-9|0.3|0.5|0.4|81|Incidence|19141933|Acute Myeloid|2001
10-14|0.1|0.2|0.2|36|Mortality|20887927|Soft Tissue|2001
5-9|2.9|3.4|3.1|586|Incidence|18856401|Acute Lymphocytic|2002
<1|3.5|4.8|4.1|154|Incidence|3761784|Leukemia|2002
1-4|0.1|0.2|0.1|23|Mortality|15548021|Soft Tissue|2002
15-19|0.2|0.4|0.3|58|Mortality|20346043|Soft Tissue|2002
15-19|0.3|0.5|0.4|82|Mortality|20446240|Acute Lymphocytic|2003
1-4|0.7|1.0|0.8|133|Mortality|15738126|Leukemia|2003
<1|0.5|1.1|0.7|30|Mortality|4032152|Leukemia|2003
5-9|3.5|4.1|3.8|736|Incidence|19353639|Leukemia|2003
5-9|0.4|0.6|0.5|101|Mortality|19737870|Other|2003
1-4|3.9|4.6|4.2|652|Incidence|15428404|Other|2003
10-14|2.8|3.0|2.9|2906|Incidence|101064898|Leukemia|2003-2007
1-4|0.7|0.8|0.7|598|Mortality|80636900|Other|2003-2007
15-19|0.4|0.6|0.4|93|Mortality|20677486|Acute Lymphocytic|2004
<1|1.6|2.5|2.0|81|Incidence|4092369|Acute Lymphocytic|2004
5-9|0.4|0.6|0.5|101|Incidence|19579623|Soft Tissue|2004
5-9|2.9|3.4|3.1|605|Incidence|19505775|Acute Lymphocytic|2005
<1|1.5|2.4|1.9|79|Incidence|4101644|Acute Lymphocytic|2005
1-4|0.6|0.9|0.7|120|Mortality|16199802|Leukemia|2005
10-14|0.3|0.4|0.3|69|Mortality|20562276|Acute Lymphocytic|2006
15-19|0.3|0.4|0.3|71|Mortality|21246129|Acute Myeloid|2006
<1|~|~|~|~|Mortality|4159778|Acute Myeloid|2006
15-19|0.7|0.9|0.8|172|Incidence|21246129|Acute Myeloid|2006
<1|~|~|~|~|Mortality|4273543|Acute Lymphocytic|2007
15-19|0.2|0.4|0.3|66|Mortality|21445610|Acute Myeloid|2007
1-4|8.2|9.1|8.7|1415|Incidence|16301645|Leukemia|2007
5-9|0.2|0.4|0.3|65|Mortality|20606460|Acute Lymphocytic|1999
10-14|0.5|0.7|0.6|110|Incidence|18331872|Acute Myeloid|1999
1-4|0.7|1.1|0.9|125|Incidence|13908887|Soft Tissue|1999
5-9|0.1|0.1|0.1|19|Mortality|20474990|Bones and Joints|2000
<1|~|~|~|~|Incidence|3485395|Bones and Joints|2000
1-4|0.2|0.4|0.3|41|Mortality|15322194|Acute Lymphocytic|2001
10-14|0.2|0.3|0.2|46|Mortality|20887927|Acute Myeloid|2001
1-4|8.5|9.5|9.0|1308|Incidence|14487799|Leukemia|2001
10-14|2.7|3.2|3.0|583|Incidence|19760108|Leukemia|2001
<1|~|~|~|~|Mortality|3985649|Acute Myeloid|2002
1-4|0.7|1.0|0.9|125|Incidence|14671443|Acute Myeloid|2002
5-9|1.4|1.8|1.6|297|Incidence|18856401|Other|2002
10-14|0.7|1.0|0.8|165|Incidence|19925443|Soft Tissue|2002
5-9|3.0|3.5|3.2|619|Incidence|19353639|Acute Lymphocytic|2003
10-14|0.2|0.3|0.3|55|Mortality|21178064|Acute Myeloid|2003
10-14|0.2|0.4|0.3|64|Mortality|21178064|Bones and Joints|2003
<1|~|~|~|~|Mortality|4032152|Bones and Joints|2003
15-19|8.4|9.2|8.8|1757|Incidence|20061631|Other|2003
5-9|0.1|0.1|0.1|70|Mortality|98315139|Bones and Joints|2003-2007
1-4|8.3|8.7|8.5|6648|Incidence|78339910|Leukemia|2003-2007
15-19|0.6|0.7|0.6|657|Mortality|104809251|Other|2003-2007
1-4|7.1|8.0|7.6|1207|Incidence|15966362|Acute Lymphocytic|2004
5-9|0.7|0.9|0.8|156|Mortality|19579623|Leukemia|2004
15-19|2.7|3.1|2.9|595|Incidence|20677486|Leukemia|2004
5-9|1.4|1.7|1.5|303|Incidence|19579623|Other|2004
<1|11.0|13.2|12.0|493|Incidence|4092369|Other|2004
15-19|0.3|0.5|0.4|79|Mortality|20993786|Acute Lymphocytic|2005
<1|1.0|1.7|1.3|53|Incidence|4101644|Acute Myeloid|2005
1-4|0.1|0.3|0.2|32|Incidence|16199802|Bones and Joints|2005
15-19|0.9|1.2|1.1|223|Mortality|20993786|Leukemia|2005
<1|3.7|5.0|4.3|177|Incidence|4101644|Leukemia|2005
15-19|0.5|0.7|0.6|120|Mortality|20993786|Other|2005
5-9|0.4|0.6|0.5|90|Mortality|19505775|Other|2005
1-4|0.1|0.2|0.1|21|Mortality|16199802|Soft Tissue|2005
10-14|0.7|0.9|0.8|167|Incidence|20823279|Soft Tissue|2005
<1|3.1|4.3|3.6|149|Incidence|4101644|Soft Tissue|2005
10-14|0.1|0.3|0.2|42|Mortality|20562276|Acute Myeloid|2006
10-14|0.1|0.2|0.2|37|Mortality|20562276|Bones and Joints|2006
<1|~|~|~|~|Mortality|4159778|Bones and Joints|2006
5-9|0.1|0.2|0.2|31|Mortality|19654941|Soft Tissue|2006
5-9|0.5|0.7|0.6|112|Incidence|19654941|Soft Tissue|2006
15-19|0.4|0.6|0.5|111|Mortality|21445610|Bones and Joints|2007
15-19|1.3|1.6|1.4|308|Incidence|21283988|Bones and Joints|2007
5-9|0.5|0.7|0.6|111|Incidence|19657805|Bones and Joints|2007
5-9|0.1|0.2|0.1|29|Mortality|20606460|Acute Myeloid|1999
1-4|7.6|8.5|8.0|1119|Incidence|13908887|Leukemia|1999
5-9|1.0|1.3|1.2|220|Incidence|18696975|Other|1999
<1|2.4|3.6|2.9|101|Incidence|3432436|Soft Tissue|1999
1-4|6.7|7.6|7.2|998|Incidence|13887421|Acute Lymphocytic|2000
5-9|0.3|0.5|0.4|71|Incidence|18571375|Acute Myeloid|2000
5-9|0.3|0.5|0.4|84|Mortality|20229583|Acute Lymphocytic|2001
15-19|1.4|1.8|1.6|303|Incidence|19191395|Acute Lymphocytic|2001
15-19|7.9|8.7|8.3|1590|Incidence|19191395|Other|2001
1-4|6.7|7.6|7.1|1047|Incidence|14671443|Acute Lymphocytic|2002
<1|1.4|2.3|1.8|67|Incidence|3761784|Acute Lymphocytic|2002
15-19|0.4|0.6|0.5|94|Mortality|20346043|Bones and Joints|2002
1-4|8.1|9.0|8.5|1254|Incidence|14671443|Leukemia|2002
<1|0.5|1.1|0.8|31|Mortality|3985649|Other|2002
5-9|0.5|0.8|0.6|121|Incidence|18856401|Soft Tissue|2002
1-4|6.4|7.2|6.8|1048|Incidence|15428404|Acute Lymphocytic|2003
10-14|1.6|2.0|1.8|366|Incidence|20766925|Acute Lymphocytic|2003
<1|1.0|1.7|1.3|52|Incidence|3954649|Acute Myeloid|2003
15-19|0.8|1.0|0.9|183|Mortality|20446240|Leukemia|2003
1-4|7.6|8.5|8.1|1247|Incidence|15428404|Leukemia|2003
10-14|2.4|2.8|2.6|539|Incidence|20766925|Leukemia|2003
1-4|0.2|0.3|0.3|226|Mortality|80636900|Acute Lymphocytic|2003-2007
5-9|0.3|0.4|0.4|371|Mortality|98315139|Acute Lymphocytic|2003-2007
10-14|1.8|2.0|1.9|1934|Incidence|101064898|Acute Lymphocytic|2003-2007
5-9|3.1|3.3|3.2|3041|Incidence|95517738|Acute Lymphocytic|2003-2007
10-14|0.2|0.3|0.2|243|Mortality|103954108|Acute Myeloid|2003-2007
15-19|0.5|0.6|0.5|568|Mortality|104809251|Bones and Joints|2003-2007
5-9|3.7|3.9|3.8|3650|Incidence|95517738|Leukemia|2003-2007
5-9|0.3|0.5|0.4|83|Mortality|19579623|Acute Lymphocytic|2004
<1|~|~|~|~|Mortality|4092369|Acute Lymphocytic|2004
10-14|0.6|0.9|0.7|156|Mortality|21098577|Leukemia|2004
15-19|0.9|1.2|1.0|210|Mortality|20677486|Leukemia|2004
5-9|3.6|4.2|3.9|764|Incidence|19579623|Leukemia|2004
<1|3.8|5.1|4.4|181|Incidence|4092369|Leukemia|2004
<1|~|~|~|~|Mortality|4092369|Soft Tissue|2004
<1|~|~|~|~|Mortality|4101644|Soft Tissue|2005
5-9|2.9|3.4|3.1|619|Incidence|19654941|Acute Lymphocytic|2006
15-19|0.8|1.1|1.0|207|Mortality|21246129|Leukemia|2006
5-9|0.4|0.6|0.5|104|Mortality|19654941|Leukemia|2006
<1|~|~|~|~|Mortality|4273543|Bones and Joints|2007
1-4|0.1|0.3|0.2|33|Incidence|16301645|Bones and Joints|2007
1-4|0.5|0.8|0.6|106|Mortality|16456673|Leukemia|2007
5-9|0.4|0.6|0.5|103|Mortality|19836930|Other|2007
<1|10.3|12.3|11.2|476|Incidence|4233070|Other|2007
15-19|1.1|1.4|1.2|258|Incidence|21283988|Soft Tissue|2007
10-14|1.8|2.2|2.0|370|Incidence|18331872|Acute Lymphocytic|1999
5-9|0.4|0.6|0.5|86|Incidence|18696975|Acute Myeloid|1999
<1|~|~|~|~|Mortality|3795762|Bones and Joints|1999
5-9|0.5|0.7|0.6|105|Incidence|18696975|Bones and Joints|1999
10-14|2.6|3.1|2.9|526|Incidence|18331872|Leukemia|1999
10-14|2.1|2.6|2.3|429|Incidence|18331872|Other|1999
15-19|0.4|0.6|0.5|98|Mortality|20259270|Acute Lymphocytic|2000
15-19|0.3|0.5|0.4|77|Mortality|20259270|Acute Myeloid|2000
<1|4.0|5.5|4.7|164|Incidence|3485395|Leukemia|2000
5-9|1.1|1.4|1.2|224|Incidence|18571375|Other|2000
1-4|0.1|0.2|0.1|20|Mortality|15330856|Soft Tissue|2000
15-19|0.4|0.6|0.5|101|Mortality|20297606|Bones and Joints|2001
<1|0.2|0.7|0.4|17|Mortality|4026137|Other|2001
1-4|1.0|1.4|1.2|176|Incidence|14487799|Soft Tissue|2001
15-19|1.4|1.8|1.6|310|Incidence|19203368|Acute Lymphocytic|2002
5-9|0.1|0.2|0.1|21|Mortality|19965243|Bones and Joints|2002
10-14|0.1|0.3|0.2|41|Mortality|21098045|Soft Tissue|2002
<1|3.7|5.0|4.3|170|Incidence|3954649|Leukemia|2003
<1|0.4|0.9|0.6|23|Mortality|4032152|Other|2003
<1|1.8|2.2|2.0|397|Incidence|20070646|Acute Lymphocytic|2003-2007
10-14|0.3|0.4|0.3|350|Mortality|103954108|Other|2003-2007
10-14|0.1|0.2|0.2|173|Mortality|103954108|Soft Tissue|2003-2007
5-9|0.5|0.6|0.6|550|Incidence|95517738|Soft Tissue|2003-2007
10-14|2.6|3.1|2.8|600|Incidence|21098577|Other|2004
15-19|1.1|1.4|1.2|250|Incidence|20677486|Soft Tissue|2004
15-19|0.3|0.4|0.4|75|Mortality|20993786|Acute Myeloid|2005
5-9|0.1|0.1|0.1|17|Mortality|19505775|Bones and Joints|2005
1-4|4.1|4.7|4.4|712|Incidence|16199802|Other|2005
1-4|6.7|7.5|7.1|1152|Incidence|16275937|Acute Lymphocytic|2006
10-14|0.6|0.9|0.7|152|Mortality|20562276|Leukemia|2006
1-4|3.5|4.1|3.8|616|Incidence|16275937|Other|2006
10-14|0.7|1.0|0.9|179|Incidence|20562276|Soft Tissue|2006
10-14|0.5|0.8|0.7|132|Incidence|20114445|Acute Myeloid|2007
15-19|0.6|0.9|0.8|162|Incidence|21283988|Acute Myeloid|2007
10-14|0.2|0.4|0.3|62|Mortality|20291912|Other|2007
15-19|0.5|0.7|0.6|133|Mortality|21445610|Other|2007
<1|0.8|1.6|1.2|40|Incidence|3432436|Acute Myeloid|1999
15-19|1.2|1.6|1.4|252|Incidence|18177976|Bones and Joints|1999
1-4|0.6|0.9|0.8|119|Mortality|15339782|Leukemia|1999
10-14|1.5|1.9|1.7|323|Incidence|18696519|Acute Lymphocytic|2000
10-14|0.1|0.2|0.1|27|Mortality|20618738|Soft Tissue|2000
<1|~|~|~|~|Mortality|3855509|Soft Tissue|2000
15-19|1.1|1.4|1.2|226|Incidence|18341898|Soft Tissue|2000
1-4|0.7|1.0|0.8|122|Mortality|15322194|Other|2001
5-9|1.3|1.6|1.5|278|Incidence|19141933|Other|2001
<1|~|~|~|~|Mortality|4026137|Soft Tissue|2001
10-14|0.3|0.5|0.4|91|Mortality|21098045|Acute Lymphocytic|2002
5-9|0.3|0.5|0.4|81|Incidence|18856401|Acute Myeloid|2002
5-9|0.4|0.6|0.5|97|Mortality|19965243|Other|2002
5-9|0.3|0.5|0.4|73|Incidence|19353639|Acute Myeloid|2003
15-19|0.4|0.6|0.5|104|Mortality|20446240|Bones and Joints|2003
10-14|0.8|1.0|0.9|183|Incidence|20766925|Soft Tissue|2003
<1|0.1|0.3|0.2|38|Mortality|20659486|Acute Lymphocytic|2003-2007
1-4|0.0|0.0|0.0|17|Mortality|80636900|Bones and Joints|2003-2007
10-14|1.3|1.4|1.3|1355|Incidence|101064898|Bones and Joints|2003-2007
10-14|0.7|0.8|0.8|819|Mortality|103954108|Leukemia|2003-2007
5-9|0.6|0.7|0.7|680|Mortality|98315139|Leukemia|2003-2007
10-14|2.7|2.9|2.8|2846|Incidence|101064898|Other|2003-2007
1-4|0.7|1.0|0.9|141|Incidence|15966362|Acute Myeloid|2004
10-14|0.2|0.4|0.3|57|Mortality|21098577|Bones and Joints|2004
1-4|0.7|1.0|0.8|130|Mortality|15966362|Other|2004
10-14|1.7|2.1|1.9|391|Incidence|20823279|Acute Lymphocytic|2005
1-4|8.0|8.9|8.4|1368|Incidence|16199802|Leukemia|2005
10-14|2.6|3.1|2.9|595|Incidence|20823279|Other|2005
15-19|8.0|8.8|8.4|1777|Incidence|21246129|Other|2006
15-19|1.0|1.3|1.1|234|Incidence|21246129|Soft Tissue|2006
1-4|0.2|0.4|0.3|47|Mortality|16456673|Acute Myeloid|2007
5-9|0.1|0.2|0.1|27|Mortality|19836930|Acute Myeloid|2007
15-19|2.7|3.1|2.9|619|Incidence|21283988|Leukemia|2007
<1|0.4|0.9|0.6|26|Mortality|4273543|Other|2007
1-4|4.2|4.9|4.5|736|Incidence|16301645|Other|2007
15-19|8.5|9.3|8.9|1894|Incidence|21283988|Other|2007
10-14|0.2|0.3|0.3|54|Mortality|20213364|Acute Myeloid|1999
15-19|2.5|2.9|2.7|489|Incidence|18177976|Leukemia|1999
5-9|0.4|0.6|0.5|108|Mortality|20606460|Other|1999
10-14|1.2|1.5|1.3|250|Incidence|18696519|Bones and Joints|2000
15-19|0.6|0.8|0.7|138|Mortality|20259270|Other|2000
5-9|~|~|~|~|Mortality|20229583|Bones and Joints|2001
10-14|0.3|0.4|0.3|70|Mortality|20887927|Other|2001
5-9|0.3|0.5|0.4|88|Mortality|20229583|Other|2001
15-19|0.2|0.4|0.3|61|Mortality|20297606|Soft Tissue|2001
1-4|0.2|0.3|0.2|34|Mortality|15548021|Acute Lymphocytic|2002
5-9|0.3|0.5|0.4|82|Mortality|19965243|Acute Lymphocytic|2002
15-19|1.4|1.8|1.6|305|Incidence|19203368|Bones and Joints|2002
10-14|0.7|0.9|0.8|168|Mortality|21098045|Leukemia|2002
15-19|2.6|3.1|2.8|547|Incidence|19203368|Leukemia|2002
<1|1.5|2.4|1.9|76|Incidence|3954649|Acute Lymphocytic|2003
<1|~|~|~|~|Incidence|3954649|Bones and Joints|2003
5-9|0.4|0.6|0.5|99|Incidence|19353639|Soft Tissue|2003
5-9|0.5|0.5|0.5|488|Mortality|98315139|Other|2003-2007
1-4|1.0|1.2|1.1|844|Incidence|78339910|Soft Tissue|2003-2007
5-9|~|~|~|~|Mortality|19579623|Bones and Joints|2004
15-19|1.3|1.7|1.5|309|Incidence|20677486|Bones and Joints|2004
1-4|4.1|4.7|4.4|699|Incidence|15966362|Other|2004
<1|~|~|~|~|Mortality|4101644|Acute Lymphocytic|2005
<1|~|~|~|~|Mortality|4101644|Acute Myeloid|2005
10-14|0.5|0.7|0.6|124|Incidence|20823279|Acute Myeloid|2005
15-19|1.1|1.4|1.2|252|Incidence|20993786|Soft Tissue|2005
1-4|0.2|0.4|0.3|44|Mortality|16275937|Acute Lymphocytic|2006
15-19|1.5|1.8|1.6|349|Incidence|21246129|Acute Lymphocytic|2006
10-14|2.9|3.4|3.2|655|Incidence|20562276|Leukemia|2006
1-4|0.5|0.8|0.7|108|Mortality|16275937|Other|2006
<1|3.5|4.8|4.1|175|Incidence|4233070|Leukemia|2007
10-14|2.4|2.9|2.7|537|Incidence|20114445|Other|2007
1-4|0.7|1.0|0.8|129|Mortality|15339782|Other|1999
15-19|0.5|0.8|0.6|127|Mortality|20084602|Other|1999
5-9|0.1|0.2|0.1|28|Mortality|20606460|Soft Tissue|1999
15-19|0.7|1.0|0.8|153|Incidence|18341898|Acute Myeloid|2000
1-4|~|~|~|~|Mortality|15330856|Bones and Joints|2000
10-14|0.2|0.4|0.3|62|Mortality|20618738|Bones and Joints|2000
10-14|0.3|0.5|0.4|76|Mortality|20618738|Other|2000
<1|1.5|2.4|1.9|71|Incidence|3806227|Acute Lymphocytic|2001
1-4|~|~|~|~|Mortality|15322194|Bones and Joints|2001
1-4|0.1|0.2|0.2|22|Incidence|14487799|Bones and Joints|2001
1-4|0.9|1.2|1.0|155|Mortality|15322194|Leukemia|2001
15-19|2.6|3.1|2.9|549|Incidence|19191395|Leukemia|2001
<1|~|~|~|~|Mortality|3985649|Bones and Joints|2002
1-4|3.8|4.5|4.1|606|Incidence|14671443|Other|2002
5-9|0.4|0.5|0.4|87|Mortality|19737870|Acute Lymphocytic|2003
15-19|1.3|1.7|1.5|302|Incidence|20061631|Bones and Joints|2003
15-19|2.5|3.0|2.7|547|Incidence|20061631|Leukemia|2003
1-4|0.6|0.9|0.7|118|Mortality|15738126|Other|2003
1-4|0.8|0.9|0.8|656|Incidence|78339910|Acute Myeloid|2003-2007
10-14|0.2|0.3|0.3|273|Mortality|103954108|Bones and Joints|2003-2007
15-19|1.5|1.6|1.5|1563|Incidence|102079321|Bones and Joints|2003-2007
<1|0.1|0.2|0.2|35|Incidence|20070646|Bones and Joints|2003-2007
15-19|2.7|3.0|2.8|2905|Incidence|102079321|Leukemia|2003-2007
10-14|0.3|0.4|0.3|72|Mortality|21098577|Acute Lymphocytic|2004
<1|1.1|1.9|1.4|59|Incidence|4092369|Acute Myeloid|2004
5-9|0.3|0.4|0.3|64|Mortality|19505775|Acute Lymphocytic|2005
5-9|0.1|0.2|0.1|29|Mortality|19505775|Acute Myeloid|2005
10-14|0.3|0.5|0.4|82|Mortality|20823279|Other|2005
15-19|8.6|9.5|9.0|1898|Incidence|20993786|Other|2005
10-14|2.0|2.4|2.2|449|Incidence|20562276|Acute Lymphocytic|2006
<1|1.7|2.7|2.2|90|Incidence|4159778|Acute Lymphocytic|2006
1-4|0.7|1.0|0.9|143|Incidence|16275937|Acute Myeloid|2006
10-14|1.1|1.5|1.3|265|Incidence|20562276|Bones and Joints|2006
<1|~|~|~|~|Incidence|4159778|Bones and Joints|2006
10-14|0.3|0.4|0.3|68|Mortality|20562276|Other|2006
5-9|3.0|3.5|3.2|635|Incidence|19657805|Acute Lymphocytic|2007
1-4|0.6|0.9|0.8|124|Incidence|16301645|Acute Myeloid|2007
10-14|0.2|0.3|0.2|48|Mortality|20291912|Bones and Joints|2007
15-19|0.8|1.1|0.9|202|Mortality|21445610|Leukemia|2007
5-9|3.6|4.2|3.9|761|Incidence|19657805|Leukemia|2007
1-4|0.6|0.8|0.7|115|Mortality|16456673|Other|2007
5-9|2.8|3.3|3.0|570|Incidence|18696975|Acute Lymphocytic|1999
1-4|0.8|1.2|1.0|136|Incidence|13908887|Acute Myeloid|1999
1-4|0.1|0.3|0.2|30|Incidence|13908887|Bones and Joints|1999
<1|0.5|1.0|0.7|27|Mortality|3795762|Leukemia|1999
5-9|3.4|4.0|3.7|692|Incidence|18696975|Leukemia|1999
10-14|0.6|0.8|0.7|123|Incidence|18331872|Soft Tissue|1999
<1|0.2|0.7|0.4|16|Mortality|3855509|Acute Lymphocytic|2000
1-4|0.1|0.2|0.2|23|Incidence|13887421|Bones and Joints|2000
1-4|8.0|8.9|8.4|1172|Incidence|13887421|Leukemia|2000
10-14|2.2|2.7|2.5|461|Incidence|18696519|Leukemia|2000
10-14|2.1|2.6|2.3|438|Incidence|18696519|Other|2000
<1|8.9|11.1|10.0|347|Incidence|3485395|Other|2000
15-19|0.4|0.6|0.5|105|Mortality|20297606|Acute Lymphocytic|2001
10-14|1.8|2.2|2.0|397|Incidence|19760108|Acute Lymphocytic|2001
<1|1.0|1.8|1.3|51|Incidence|3806227|Acute Myeloid|2001
5-9|0.6|0.9|0.8|153|Mortality|20229583|Leukemia|2001
15-19|0.6|0.9|0.7|147|Mortality|20297606|Other|2001
<1|~|~|~|~|Mortality|3985649|Acute Lymphocytic|2002
10-14|0.2|0.4|0.3|61|Mortality|21098045|Bones and Joints|2002
10-14|1.2|1.5|1.4|269|Incidence|19925443|Bones and Joints|2002
5-9|0.5|0.7|0.6|114|Incidence|18856401|Bones and Joints|2002
10-14|2.6|3.0|2.8|556|Incidence|19925443|Leukemia|2002
15-19|8.4|9.2|8.8|1689|Incidence|19203368|Other|2002
1-4|1.0|1.4|1.2|177|Incidence|14671443|Soft Tissue|2002
10-14|0.3|0.5|0.4|87|Mortality|21178064|Acute Lymphocytic|2003
1-4|0.7|1.0|0.8|131|Incidence|15428404|Acute Myeloid|2003
10-14|0.5|0.7|0.6|129|Incidence|20766925|Acute Myeloid|2003
1-4|0.2|0.3|0.2|36|Incidence|15428404|Bones and Joints|2003
5-9|0.4|0.6|0.5|93|Incidence|19353639|Bones and Joints|2003
1-4|~|~|~|~|Mortality|15738126|Soft Tissue|2003
10-14|0.1|0.2|0.2|36|Mortality|21178064|Soft Tissue|2003
1-4|7.0|7.4|7.2|5648|Incidence|78339910|Acute Lymphocytic|2003-2007
15-19|0.7|0.8|0.8|805|Incidence|102079321|Acute Myeloid|2003-2007
1-4|0.7|0.8|0.7|603|Mortality|80636900|Leukemia|2003-2007
15-19|0.5|0.7|0.6|114|Mortality|20677486|Bones and Joints|2004
1-4|8.5|9.5|9.0|1434|Incidence|15966362|Leukemia|2004
15-19|0.6|0.8|0.7|152|Incidence|20993786|Acute Myeloid|2005
1-4|~|~|~|~|Mortality|16199802|Bones and Joints|2005
5-9|0.5|0.7|0.6|113|Incidence|19505775|Bones and Joints|2005
15-19|2.5|3.0|2.8|579|Incidence|20993786|Leukemia|2005
1-4|0.2|0.4|0.3|54|Mortality|16275937|Acute Myeloid|2006
15-19|1.5|1.8|1.6|348|Incidence|21246129|Bones and Joints|2006
5-9|0.3|0.5|0.4|84|Incidence|19657805|Acute Myeloid|2007
5-9|~|~|~|~|Mortality|19836930|Bones and Joints|2007
<1|~|~|~|~|Incidence|4233070|Bones and Joints|2007
<1|0.3|0.8|0.5|21|Mortality|4273543|Leukemia|2007
10-14|0.1|0.2|0.2|35|Mortality|20291912|Soft Tissue|2007
1-4|6.3|7.1|6.7|931|Incidence|13908887|Acute Lymphocytic|1999
15-19|1.2|1.6|1.4|252|Incidence|18177976|Acute Lymphocytic|1999
15-19|1.0|1.3|1.1|221|Mortality|20084602|Leukemia|1999
1-4|0.7|1.0|0.8|118|Incidence|13887421|Acute Myeloid|2000
5-9|0.4|0.6|0.5|99|Incidence|18571375|Bones and Joints|2000
15-19|1.0|1.4|1.2|242|Mortality|20259270|Leukemia|2000
5-9|3.5|4.1|3.8|703|Incidence|18571375|Leukemia|2000
<1|~|~|~|~|Mortality|4026137|Acute Lymphocytic|2001
15-19|0.3|0.4|0.3|70|Mortality|20297606|Acute Myeloid|2001
5-9|0.1|0.2|0.2|31|Mortality|20229583|Acute Myeloid|2001
10-14|0.3|0.4|0.3|72|Mortality|20887927|Bones and Joints|2001
10-14|1.2|1.6|1.4|276|Incidence|19760108|Bones and Joints|2001
<1|~|~|~|~|Incidence|3806227|Bones and Joints|2001
<1|3.4|4.7|4.0|154|Incidence|3806227|Leukemia|2001
10-14|2.4|2.9|2.7|527|Incidence|19760108|Other|2001
15-19|0.9|1.2|1.1|204|Incidence|19203368|Soft Tissue|2002
15-19|1.3|1.6|1.5|292|Incidence|20061631|Acute Lymphocytic|2003
10-14|1.2|1.5|1.4|286|Incidence|20766925|Bones and Joints|2003
5-9|1.1|1.5|1.3|250|Incidence|19353639|Other|2003
15-19|0.3|0.4|0.3|341|Mortality|104809251|Acute Myeloid|2003-2007
1-4|0.1|0.1|0.1|98|Mortality|80636900|Soft Tissue|2003-2007
1-4|0.3|0.4|0.3|55|Mortality|15966362|Acute Myeloid|2004
1-4|~|~|~|~|Mortality|15966362|Bones and Joints|2004
5-9|0.4|0.6|0.5|105|Incidence|19579623|Bones and Joints|2004
10-14|2.6|3.1|2.8|596|Incidence|21098577|Leukemia|2004
10-14|0.3|0.4|0.3|69|Mortality|21098577|Other|2004
15-19|0.6|0.9|0.7|151|Mortality|20677486|Other|2004
15-19|0.5|0.7|0.6|124|Mortality|20993786|Bones and Joints|2005
5-9|0.1|0.2|0.1|21|Mortality|19505775|Soft Tissue|2005
1-4|0.1|0.2|0.1|24|Incidence|16275937|Bones and Joints|2006
1-4|7.9|8.8|8.4|1360|Incidence|16275937|Leukemia|2006
15-19|2.8|3.2|3.0|633|Incidence|21246129|Leukemia|2006
<1|11.3|13.5|12.4|514|Incidence|4159778|Other|2006
10-14|0.1|0.2|0.1|25|Mortality|20562276|Soft Tissue|2006
15-19|1.5|1.9|1.7|355|Incidence|21283988|Acute Lymphocytic|2007
<1|~|~|~|~|Mortality|4273543|Acute Myeloid|2007
5-9|0.5|0.7|0.6|130|Mortality|20606460|Leukemia|1999
<1|3.8|5.2|4.5|153|Incidence|3432436|Leukemia|1999
<1|9.8|12.0|10.8|372|Incidence|3432436|Other|1999
<1|~|~|~|~|Mortality|3795762|Soft Tissue|1999
<1|0.7|1.4|1.0|38|Mortality|3855509|Leukemia|2000
15-19|2.5|3.0|2.7|501|Incidence|18341898|Leukemia|2000
15-19|7.5|8.4|7.9|1455|Incidence|18341898|Other|2000
1-4|0.9|1.2|1.0|145|Incidence|13887421|Soft Tissue|2000
15-19|1.5|1.9|1.7|329|Incidence|19191395|Bones and Joints|2001
15-19|1.0|1.3|1.1|225|Mortality|20297606|Leukemia|2001
5-9|3.5|4.0|3.8|720|Incidence|19141933|Leukemia|2001
10-14|0.2|0.3|0.2|44|Mortality|21098045|Acute Myeloid|2002
1-4|0.7|1.0|0.9|136|Mortality|15548021|Other|2002
10-14|0.3|0.5|0.4|78|Mortality|21098045|Other|2002
1-4|~|~|~|~|Mortality|15738126|Bones and Joints|2003
5-9|0.4|0.5|0.4|394|Incidence|95517738|Acute Myeloid|2003-2007
<1|1.2|1.5|1.3|266|Incidence|20070646|Acute Myeloid|2003-2007
<1|3.0|3.5|3.3|656|Incidence|20070646|Soft Tissue|2003-2007
1-4|0.2|0.4|0.3|42|Mortality|15966362|Acute Lymphocytic|2004
10-14|1.3|1.6|1.5|309|Incidence|21098577|Bones and Joints|2004
1-4|0.2|0.3|0.3|41|Mortality|16199802|Acute Lymphocytic|2005
5-9|1.4|1.8|1.6|306|Incidence|19505775|Other|2005
1-4|0.1|0.2|0.1|23|Mortality|16275937|Soft Tissue|2006
<1|~|~|~|~|Mortality|4273543|Soft Tissue|2007
5-9|0.6|0.8|0.7|137|Incidence|19657805|Soft Tissue|2007
